<svg class="main-svg" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" width="700" height="500" style="" viewBox="0 0 700 500"><rect x="0" y="0" width="700" height="500" style="fill: rgb(255, 255, 255); fill-opacity: 1;"/><defs id="defs-98d03e"><g class="clips"><clipPath id="clip98d03exyplot" class="plotclip"><rect width="540" height="320"/></clipPath><clipPath class="axesclip" id="clip98d03ex"><rect x="80" y="0" width="540" height="500"/></clipPath><clipPath class="axesclip" id="clip98d03ey"><rect x="0" y="100" width="700" height="320"/></clipPath><clipPath class="axesclip" id="clip98d03exy"><rect x="80" y="100" width="540" height="320"/></clipPath></g><g class="gradients"/><g class="patterns"/></defs><g class="bglayer"><rect class="bg" x="80" y="100" width="540" height="320" style="fill: rgb(229, 236, 246); fill-opacity: 1; stroke-width: 0;"/></g><g class="layer-below"><g class="imagelayer"/><g class="shapelayer"/></g><g class="cartesianlayer"><g class="subplot xy"><g class="layer-subplot"><g class="shapelayer"/><g class="imagelayer"/></g><g class="minor-gridlayer"><g class="x"/><g class="y"/></g><g class="gridlayer"><g class="x"><path class="xgrid crisp" transform="translate(159.53,0)" d="M0,100v320" style="stroke: rgb(255, 255, 255); stroke-opacity: 1; stroke-width: 1px;"/><path class="xgrid crisp" transform="translate(239.06,0)" d="M0,100v320" style="stroke: rgb(255, 255, 255); stroke-opacity: 1; stroke-width: 1px;"/><path class="xgrid crisp" transform="translate(318.58000000000004,0)" d="M0,100v320" style="stroke: rgb(255, 255, 255); stroke-opacity: 1; stroke-width: 1px;"/><path class="xgrid crisp" transform="translate(398.11,0)" d="M0,100v320" style="stroke: rgb(255, 255, 255); stroke-opacity: 1; stroke-width: 1px;"/><path class="xgrid crisp" transform="translate(477.64,0)" d="M0,100v320" style="stroke: rgb(255, 255, 255); stroke-opacity: 1; stroke-width: 1px;"/><path class="xgrid crisp" transform="translate(557.1700000000001,0)" d="M0,100v320" style="stroke: rgb(255, 255, 255); stroke-opacity: 1; stroke-width: 1px;"/></g><g class="y"/></g><g class="zerolinelayer"><path class="xzl zl crisp" transform="translate(80,0)" d="M0,100v320" style="stroke: rgb(255, 255, 255); stroke-opacity: 1; stroke-width: 2px;"/></g><path class="xlines-below"/><path class="ylines-below"/><g class="overlines-below"/><g class="xaxislayer-below"/><g class="yaxislayer-below"/><g class="overaxes-below"/><g class="plot" transform="translate(80,100)" clip-path="url(#clip98d03exyplot)"><g class="barlayer mlayer"><g class="trace bars" style="opacity: 1;"><g class="points"><g class="point"><path d="M0,319.95V319.52H11.4V319.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(5.69329204087953,319.8027856921648)scale(0.015063487147723754)">Hereditary Breast and Ovarian Cancer Syndrome/Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway</text></g><g class="point"><path d="M0,319.41V318.99H11.46V319.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(5.721186068230511,319.29065758391476)scale(0.020146129758830962)">Hereditary Breast and Ovarian Cancer Syndrome/ERBB/VEGFR/Akt Signaling in Breast Cancer</text></g><g class="point"><path d="M0,318.88V318.45H11.57V318.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(5.780118721596376,318.7143266028155)scale(0.01096146729234823)">Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome/Proteins Involved in Breast Cancer Related to ERBB2/VEGFR/Akt Signaling Pathway</text></g><g class="point"><path d="M0,318.35V317.92H11.61V318.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(5.801628103974055,318.21592550462265)scale(0.017983445471707247)">Multi-Treatment Models Breast Cancer GSE136823 3/Breast Cancer C0006142 human GSE2155 sample 39</text></g><g class="point"><path d="M0,317.81V317.39H11.61V317.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(5.805,317.68272340425534)scale(0.018382978723404254)">Multi-Treatment Models Breast Cancer GSE136823 2/Differentially Breast Cancer Diabetes GSE150586 1</text></g><g class="point"><path d="M0,317.28V316.85H11.61V317.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(5.801628103974055,317.14592550462265)scale(0.017983445471707247)">Multi-Treatment Models Breast Cancer GSE136823 4/Breast Cancer C0006142 human GSE2155 sample 39</text></g><g class="point"><path d="M0,316.75V316.32H11.9V316.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(5.944475217725411,316.58986680327865)scale(0.012192622950819673)">Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome/Proteins Involved in Breast Cancer Related to ESR1 Signaling Pathway</text></g><g class="point"><path d="M0,316.21V315.79H11.92V316.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(5.96,316.07497182791)scale(0.01666040620222756)">Breast Cancer C0006142 human GSE1379 sample 392/estradiol human MCF-7 breast cancer cells GDS3283 ligand:43</text></g><g class="point"><path d="M0,315.68V315.25H12.05V315.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.025,315.54572199478974)scale(0.01793822106438407)">Integrated Breast Cancer Pathway Homo sapiens WP1984/Multi-Treatment Models Breast Cancer GSE136823 3</text></g><g class="point"><path d="M0,315.15V314.72H12.17V315.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.085,315.01973455178415)scale(0.01882990039648003)">breast cancer DOID-1612 human GSE26910 sample 602/Breast Cancer C0006142 rat GSE1872 sample 63</text></g><g class="point"><path d="M0,314.61V314.19H12.18V314.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.086462558691127,314.4848985914129)scale(0.01886635364732078)">Multi-Treatment Models Breast Cancer GSE136823 1/Breast Cancer C0006142 human GSE1378 sample 52</text></g><g class="point"><path d="M0,314.08V313.65H12.22V314.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.11,313.96941345754465)scale(0.02320299056547796)">Integrated breast cancer pathway/Multi-Treatment Models Breast Cancer GSE136823 3</text></g><g class="point"><path d="M0,313.55V313.12H12.22V313.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.11,313.4297286821706)scale(0.021050818260120587)">Integrated breast cancer pathway WP1984/Multi-Treatment Models Breast Cancer GSE136823 3</text></g><g class="point"><path d="M0,313.01V312.59H12.26V313.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.119913615795968,312.9037456660986)scale(0.02305459246635717)">Hereditary Breast and Ovarian Cancer Syndrome/IGF1R/AKT Signaling in Breast Cancer</text></g><g class="point"><path d="M0,312.48V312.05H12.27V312.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.135,312.3597337944346)scale(0.02105195431880328)">Integrated Breast Cancer Pathway WP1984/Multi-Treatment Models Breast Cancer GSE136823 3</text></g><g class="point"><path d="M0,311.95V311.52H12.32V311.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.154455961765254,311.79005803488303)scale(0.01223511886288871)">Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome/Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway</text></g><g class="point"><path d="M0,311.41V310.99H12.37V311.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.1769421179973945,311.28288107202684)scale(0.018418016005955704)">Proteins Involved in Breast Cancer Related to NOTCH Signaling Pathway/IGF1R/AKT Signaling in Breast Cancer</text></g><g class="point"><path d="M0,310.88V310.45H12.5V310.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.246633568300508,310.7493071590829)scale(0.0187349242406501)">Breast Cancer C0006142 human GSE2429 sample 148/Breast Cancer C0006142 human GSE1379 sample 392</text></g><g class="point"><path d="M0,310.35V309.92H12.5V310.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.2466605815040745,310.2151460439022)scale(0.01781023197827152)">Multi-Treatment Models Breast Cancer GSE136823 7/estradiol human MCF-7 breast cancer cells GDS3105 ligand:38</text></g><g class="point"><path d="M0,309.81V309.39H13.44V309.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.711876656840498,309.68208852034866)scale(0.018241893410811613)">Hereditary Breast and Ovarian Cancer Syndrome/Proteins Involved in Breast Cancer Related to NOTCH Signaling Pathway</text></g><g class="point"><path d="M0,309.28V308.85H13.72V309.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.857112288209914,309.1343050829621)scale(0.015401129547128776)">Multi-Treatment Models Breast Cancer GSE136823 6/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:39</text></g><g class="point"><path d="M0,308.75V308.32H13.86V308.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.926297252771716,308.6238659334787)scale(0.019747985217507456)">Multi-Treatment Models Breast Cancer GSE136823 4/estradiol human MCF-7 breast cancer cells GDS3105 ligand:38</text></g><g class="point"><path d="M0,308.21V307.79H14.22V308.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.105870080836439,308.09911805992544)scale(0.02202623553899027)">Multi-Treatment Models Breast Cancer GSE136823 6/Breast Cancer C0006142 human GSE2155 sample 39</text></g><g class="point"><path d="M0,307.68V307.25H14.37V307.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.182174041297935,307.53282300884956)scale(0.015071779744346115)">estradiol human MCF-7 breast cancer cells GDS3283 ligand:42/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:39</text></g><g class="point"><path d="M0,307.15V306.72H14.87V307.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.435,307.0089852118029)scale(0.016441158178425817)">Breast Cancer C0006142 human GSE2429 sample 148/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:41</text></g><g class="point"><path d="M0,306.61V306.19H14.9V306.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.446863928157997,306.47526572420804)scale(0.0167257164906865)">Multi-Treatment Models Breast Cancer GSE136823 3/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:39</text></g><g class="point"><path d="M0,306.08V305.65H15.38V306.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.685985033066482,305.96135920640444)scale(0.02141315697876784)">Breast Cancer C0006142 human GSE1378 sample 52/sporadic breast cancer DOID-8029 human GSE3744 sample 979</text></g><g class="point"><path d="M0,305.55V305.12H15.62V305.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.806712386431402,305.4139027256464)scale(0.017533939032518327)">Multi-Treatment Models Breast Cancer GSE136823 6/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:40</text></g><g class="point"><path d="M0,305.01V304.59H15.76V305.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.876734129999309,304.87838088001655)scale(0.017417973337017337)">Breast Cancer C0006142 human GSE2429 sample 148/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:40</text></g><g class="point"><path d="M0,304.48V304.05H15.83V304.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.363750000000117,304.394)scale(0.02866666666666712)">Breast cancer pathway WP4262/Genes with Mutations Associated with Breast Cancer</text></g><g class="point"><path d="M0,303.95V303.52H16.43V303.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.211722834099383,303.8170716329893)scale(0.018238140664296243)">Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome/Integrated Breast Cancer Pathway Homo sapiens WP1984</text></g><g class="point"><path d="M0,303.41V302.99H16.45V303.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.225,303.2997263503558)scale(0.022161411190165452)">Breast cancer pathway WP4262/Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome</text></g><g class="point"><path d="M0,302.88V302.45H16.51V302.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.255,302.7568107742807)scale(0.02040239428461093)">Integrated breast cancer pathway WP1984/Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome</text></g><g class="point"><path d="M0,302.35V301.92H16.51V302.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.255,302.2333510528275)scale(0.021855789517229968)">Integrated breast cancer pathway/Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome</text></g><g class="point"><path d="M0,301.81V301.39H16.53V301.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.261182741898237,301.6916141944423)scale(0.020358709876068047)">Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome/Integrated Breast Cancer Pathway WP1984</text></g><g class="point"><path d="M0,301.28V300.85H16.63V301.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.315,301.1616704343614)scale(0.021482318746972387)">sporadic breast cancer DOID-8029 human GSE3744 sample 979/estradiol human MCF-7 breast cancer cells GDS3283 ligand:43</text></g><g class="point"><path d="M0,300.75V300.32H16.64V300.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.32,300.6532238010657)scale(0.02627195579238208)">Breast cancer/Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome</text></g><g class="point"><path d="M0,300.21V299.79H16.79V300.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.3906283631314,300.1049192848464)scale(0.023315396632529073)">breast cancer DOID-1612 human GSE9574 sample 448/estradiol human MCF-7 breast cancer cells GDS3283 ligand:42</text></g><g class="point"><path d="M0,299.68V299.25H17.09V299.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.545,299.55075371106005)scale(0.019056380235556485)">Breast Cancer C0006142 human GSE2155 sample 39/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:41</text></g><g class="point"><path d="M0,299.15V298.72H17.26V299.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.838541666665755,299.06399999999996)scale(0.028666666666663333)">WNT Signaling in Breast Cancer/Integrated Breast Cancer Pathway Homo sapiens WP1984</text></g><g class="point"><path d="M0,298.61V298.19H17.37V298.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.681369905956114,298.4871222570533)scale(0.01936050156739812)">Breast Cancer C0006142 human GSE2155 sample 39/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:39</text></g><g class="point"><path d="M0,298.08V297.65H17.38V298.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(5.758864583333424,297.994)scale(0.02866666666666712)">Integrated breast cancer pathway/WNT Signaling in Breast Cancer</text></g><g class="point"><path d="M0,297.55V297.12H17.38V297.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.530625000000104,297.46400000000006)scale(0.02866666666666712)">Integrated breast cancer pathway WP1984/WNT Signaling in Breast Cancer</text></g><g class="point"><path d="M0,297.01V296.59H17.42V297.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.411562500000243,296.92599999999993)scale(0.028000000000001062)">WNT Signaling in Breast Cancer/Integrated Breast Cancer Pathway WP1984</text></g><g class="point"><path d="M0,296.48V296.05H17.59V296.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.790397095381396,296.3754697108465)scale(0.024548824632561386)">sporadic breast cancer DOID-8029 human GSE3744 sample 979/Breast Cancer C0006142 mouse GSE2528 sample 28</text></g><g class="point"><path d="M0,295.95V295.52H17.95V295.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.963721145578411,295.84897579204977)scale(0.02532795378883083)">Proteins Involved in Breast Cancer Related to NOTCH Signaling Pathway/ERBB/VEGFR/Akt Signaling in Breast Cancer</text></g><g class="point"><path d="M0,295.41V294.99H18.24V295.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.903125000000339,295.326)scale(0.028000000000001062)">Proteins Involved in Breast Cancer Related to NOTCH Signaling Pathway/ESR1 Signaling in Breast Cancer</text></g><g class="point"><path d="M0,294.88V294.45H18.47V294.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.443281250000102,294.794)scale(0.02866666666666712)">NOTCH1 Signaling in Breast Cancer/IGF1R/AKT Signaling in Breast Cancer</text></g><g class="point"><path d="M0,294.35V293.92H18.5V294.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.25,294.22849008598)scale(0.020775574662221442)">Multi-Treatment Models Breast Cancer GSE136823 4/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:41</text></g><g class="point"><path d="M0,293.81V293.39H18.62V293.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.188375000000349,293.726)scale(0.028000000000001062)">Proteins Involved in Breast Cancer Related to WNT Signaling Pathway/IGF1R/AKT Signaling in Breast Cancer</text></g><g class="point"><path d="M0,293.28V292.85H18.83V293.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.373552083332243,293.19399999999996)scale(0.028666666666663333)">Proteins with Altered Expression in Breast Cancer/Integrated Breast Cancer Pathway Homo sapiens WP1984</text></g><g class="point"><path d="M0,292.75V292.32H18.95V292.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.293875000000115,292.664)scale(0.02866666666666712)">Integrated breast cancer pathway/Proteins with Altered Expression in Breast Cancer</text></g><g class="point"><path d="M0,292.21V291.79H18.95V292.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.877624999999232,292.126)scale(0.02799999999999727)">Integrated breast cancer pathway WP1984/Proteins with Altered Expression in Breast Cancer</text></g><g class="point"><path d="M0,291.68V291.25H18.95V291.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.475,291.5544747196538)scale(0.019883271034166174)">estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:41/estradiol human MCF-7 breast cancer cells GDS3283 ligand:43</text></g><g class="point"><path d="M0,291.15V290.72H18.98V291.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.098781249999059,291.06399999999996)scale(0.028666666666663333)">Proteins with Altered Expression in Breast Cancer/Integrated Breast Cancer Pathway WP1984</text></g><g class="point"><path d="M0,290.61V290.19H20.21V290.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.100320911598317,290.5171806486682)scale(0.02604014414849711)">Proteins Involved in Breast Cancer Related to WNT Signaling Pathway/Integrated Breast Cancer Pathway Homo sapiens WP1984</text></g><g class="point"><path d="M0,290.08V289.65H20.34V290.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.039406250000143,289.994)scale(0.02866666666666712)">Integrated breast cancer pathway/Proteins Involved in Breast Cancer Related to WNT Signaling Pathway</text></g><g class="point"><path d="M0,289.55V289.12H20.34V289.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.810718750000156,289.46400000000006)scale(0.02866666666666712)">Integrated breast cancer pathway WP1984/Proteins Involved in Breast Cancer Related to WNT Signaling Pathway</text></g><g class="point"><path d="M0,289.01V288.59H20.39V289.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.615375000000364,288.92599999999993)scale(0.028000000000001062)">Proteins Involved in Breast Cancer Related to WNT Signaling Pathway/Integrated Breast Cancer Pathway WP1984</text></g><g class="point"><path d="M0,288.48V288.05H20.78V288.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.938375000000157,288.394)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to WNT Signaling Pathway/ERBB/VEGFR/Akt Signaling in Breast Cancer</text></g><g class="point"><path d="M0,287.95V287.52H21.05V287.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(5.49280208333342,287.86400000000003)scale(0.02866666666666712)">Breast cancer/Hereditary Breast and Ovarian Cancer Syndrome</text></g><g class="point"><path d="M0,287.41V286.99H21.13V287.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.560552671273722,287.3067358894307)scale(0.023719086540148034)">Multi-Treatment Models Breast Cancer GSE136823 3/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:40</text></g><g class="point"><path d="M0,286.88V286.45H21.33V286.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.043635416666826,286.794)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to NOTCH Signaling Pathway/ESR1/ERBB Positive Luminal Breast Cancer</text></g><g class="point"><path d="M0,286.35V285.92H21.45V286.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.248135416666813,286.264)scale(0.02866666666666712)">Multi-Treatment Models Breast Cancer GSE136823 7/Breast Cancer C0006142 human GSE2155 sample 39</text></g><g class="point"><path d="M0,285.81V285.39H21.45V285.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.033062500000343,285.726)scale(0.028000000000001062)">Multi-Treatment Models Breast Cancer GSE136823 5/Breast Cancer C0006142 human GSE2155 sample 39</text></g><g class="point"><path d="M0,285.28V284.85H21.65V285.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.339062499998914,285.19399999999996)scale(0.028666666666663333)">Breast Cancer C0006142 human GSE1378 sample 52/Breast Cancer C0006142 human GSE3744 sample 24</text></g><g class="point"><path d="M0,284.75V284.32H21.94V284.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.126604166666763,284.664)scale(0.02866666666666712)">WNT Signaling in Breast Cancer/IGF1R/AKT Signaling in Breast Cancer</text></g><g class="point"><path d="M0,284.21V283.79H22.13V284.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.896999999999133,284.126)scale(0.02799999999999727)">Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome/Breast Cancer</text></g><g class="point"><path d="M0,283.68V283.25H22.22V283.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(11.105417296851368,283.5749848755672)scale(0.024441083459370273)">breast cancer DOID-1612 human GSE9574 sample 448/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:39</text></g><g class="point"><path d="M0,283.15V282.72H22.4V283.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.776677083332196,283.06399999999996)scale(0.028666666666663333)">Breast cancer DOID-1612 mouse GSE24594 sample 616/breast cancer DOID-1612 human GSE9574 sample 448</text></g><g class="point"><path d="M0,282.61V282.19H22.53V282.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(11.265,282.51156533700134)scale(0.024792297111416783)">breast cancer DOID-1612 human GSE9574 sample 448/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:41</text></g><g class="point"><path d="M0,282.08V281.65H22.62V282.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.313979166666813,281.994)scale(0.02866666666666712)">Differentially Breast Cancer Diabetes GSE150586 1/breast cancer DOID-1612 human GSE9574 sample 448</text></g><g class="point"><path d="M0,281.55V281.12H22.62V281.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.424166666666816,281.46400000000006)scale(0.02866666666666712)">Breast Cancer C0006142 human GSE2429 sample 148/Breast Cancer C0006142 mouse GSE2528 sample 28</text></g><g class="point"><path d="M0,281.01V280.59H22.87V281.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(11.354437500000431,280.92599999999993)scale(0.028000000000001062)">Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome/ESR1/ERBB Positive Luminal Breast Cancer</text></g><g class="point"><path d="M0,280.48V280.05H22.95V280.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(11.475,280.3840061217141)scale(0.026445804825351096)">Genes with Mutations Associated with Breast Cancer/Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome</text></g><g class="point"><path d="M0,279.95V279.52H23.18V279.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.510166666666818,279.86400000000003)scale(0.02866666666666712)">Breast Cancer C0006142 human GSE1378 sample 52/breast cancer DOID-1612 human GSE3744 sample 978</text></g><g class="point"><path d="M0,279.41V278.99H23.28V279.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(11.635233577887734,279.31439413069444)scale(0.0254209179320935)">Breast cancer DOID-1612 mouse GSE24594 sample 616/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:39</text></g><g class="point"><path d="M0,278.88V278.45H23.3V278.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.715312500000154,278.794)scale(0.02866666666666712)">Breast cancer DOID-1612 mouse GSE24594 sample 616/Breast Cancer C0006142 human GSE2429 sample 148</text></g><g class="point"><path d="M0,278.35V277.92H23.64V278.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(11.815124432833768,278.2520136119895)scale(0.026003024886566754)">breast cancer DOID-1612 human GSE9574 sample 448/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:40</text></g><g class="point"><path d="M0,277.81V277.39H23.8V277.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.607937500000364,277.726)scale(0.028000000000001062)">Proteins Involved in Breast Cancer Related to WNT Signaling Pathway/ESR1/ERBB Positive Luminal Breast Cancer</text></g><g class="point"><path d="M0,277.28V276.85H24.01V277.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.657833333332559,277.19399999999996)scale(0.028666666666663333)">WNT Signaling in Breast Cancer/ERBB/VEGFR/Akt Signaling in Breast Cancer</text></g><g class="point"><path d="M0,276.75V276.32H24.01V276.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.974510416666777,276.664)scale(0.02866666666666712)">NOTCH1 Signaling in Breast Cancer/ERBB/VEGFR/Akt Signaling in Breast Cancer</text></g><g class="point"><path d="M0,276.21V275.79H24.06V276.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.024971786833856,276.12067711598746)scale(0.0268171368861024)">Breast Cancer C0006142 human GSE2155 sample 39/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:40</text></g><g class="point"><path d="M0,275.68V275.25H24.3V275.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.145221238938054,275.57969026548676)scale(0.025486725663716816)">estradiol human MCF-7 breast cancer cells GDS3283 ligand:43/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:40</text></g><g class="point"><path d="M0,275.15V274.72H24.33V275.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.160018597508957,275.05455365978503)scale(0.02656747995222658)">Breast cancer DOID-1612 mouse GSE24594 sample 616/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:40</text></g><g class="point"><path d="M0,274.61V274.19H24.39V274.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(5.80562500000022,274.52599999999995)scale(0.028000000000001062)">NOTCH1 Signaling in Breast Cancer/ESR1 Signaling in Breast Cancer</text></g><g class="point"><path d="M0,274.08V273.65H24.49V274.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.460197916666832,273.994)scale(0.02866666666666712)">breast cancer DOID-1612 human GSE9574 sample 448/sporadic breast cancer DOID-8029 human GSE3744 sample 979</text></g><g class="point"><path d="M0,273.55V273.12H24.59V273.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.907718750000141,273.46400000000006)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to WNT Signaling Pathway/ESR1 Signaling in Breast Cancer</text></g><g class="point"><path d="M0,273.01V272.59H25.18V273.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.59,272.9237811081145)scale(0.027506912914348137)">Breast cancer DOID-1612 mouse GSE24594 sample 616/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:41</text></g><g class="point"><path d="M0,272.48V272.05H25.47V272.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.886614583333506,272.394)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway/Proteins with Altered Expression in Breast Cancer</text></g><g class="point"><path d="M0,271.95V271.52H25.48V271.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.734637106675553,271.86370943978676)scale(0.028602097730382012)">Multi-Treatment Models Breast Cancer GSE136823 5/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:39</text></g><g class="point"><path d="M0,271.41V270.99H25.48V271.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.466562500000473,271.326)scale(0.028000000000001062)">Multi-Treatment Models Breast Cancer GSE136823 4/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:39</text></g><g class="point"><path d="M0,270.88V270.45H25.69V270.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.154770833333462,270.794)scale(0.02866666666666712)">NOTCH1 Signaling in Breast Cancer/Integrated Breast Cancer Pathway Homo sapiens WP1984</text></g><g class="point"><path d="M0,270.35V269.92H25.85V270.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.0750937500000965,270.264)scale(0.02866666666666712)">Integrated breast cancer pathway/NOTCH1 Signaling in Breast Cancer</text></g><g class="point"><path d="M0,269.81V269.39H25.85V269.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.687625000000254,269.726)scale(0.028000000000001062)">Integrated breast cancer pathway WP1984/NOTCH1 Signaling in Breast Cancer</text></g><g class="point"><path d="M0,269.28V268.85H25.9V269.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.880447916665866,269.19399999999996)scale(0.028666666666663333)">NOTCH1 Signaling in Breast Cancer/Integrated Breast Cancer Pathway WP1984</text></g><g class="point"><path d="M0,268.75V268.32H26.03V268.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.76338541666687,268.664)scale(0.02866666666666712)">Multi-Treatment Models Breast Cancer GSE136823 7/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:41</text></g><g class="point"><path d="M0,268.21V267.79H26.19V268.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.944249999999128,268.126)scale(0.02799999999999727)">Multi-Treatment Models Breast Cancer GSE136823 2/Multi-Treatment Models Breast Cancer GSE136823 4</text></g><g class="point"><path d="M0,267.68V267.25H26.89V267.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(11.326020833333512,267.59400000000005)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to NOTCH Signaling Pathway/Integrated Breast Cancer Pathway Homo sapiens WP1984</text></g><g class="point"><path d="M0,267.15V266.72H26.94V267.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.058666666665614,267.06399999999996)scale(0.028666666666663333)">Breast cancer pathway WP4262/Proteins Involved in Breast Cancer Related to NOTCH Signaling Pathway</text></g><g class="point"><path d="M0,266.61V266.19H26.98V266.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.149125000000385,266.52599999999995)scale(0.028000000000001062)">Hereditary Breast and Ovarian Cancer Syndrome/Proteins Involved in Breast Cancer Related to ESR1 Signaling Pathway</text></g><g class="point"><path d="M0,266.08V265.65H27.05V266.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.246343750000147,265.994)scale(0.02866666666666712)">Integrated breast cancer pathway/Proteins Involved in Breast Cancer Related to NOTCH Signaling Pathway</text></g><g class="point"><path d="M0,265.55V265.12H27.05V265.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.018104166666825,265.46400000000006)scale(0.02866666666666712)">Integrated breast cancer pathway WP1984/Proteins Involved in Breast Cancer Related to NOTCH Signaling Pathway</text></g><g class="point"><path d="M0,265.01V264.59H27.1V265.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.817937500000372,264.92599999999993)scale(0.028000000000001062)">Proteins Involved in Breast Cancer Related to NOTCH Signaling Pathway/Integrated Breast Cancer Pathway WP1984</text></g><g class="point"><path d="M0,264.48V264.05H27.84V264.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.157208333333479,264.394)scale(0.02866666666666712)">Multi-Treatment Models Breast Cancer GSE136823 1/Multi-Treatment Models Breast Cancer GSE136823 4</text></g><g class="point"><path d="M0,263.95V263.52H27.96V263.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(5.627625000000089,263.86400000000003)scale(0.02866666666666712)">WNT Signaling in Breast Cancer/ESR1 Signaling in Breast Cancer</text></g><g class="point"><path d="M0,263.41V262.99H28.07V263.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.199875000000388,263.326)scale(0.028000000000001062)">Proteins Involved in Breast Cancer Related to ESR1 Signaling Pathway/Proteins with Altered Expression in Breast Cancer</text></g><g class="point"><path d="M0,262.88V262.45H29.32V262.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.314875000000148,262.794)scale(0.02866666666666712)">Breast Cancer C0006142 mouse GSE2528 sample 28/Breast Cancer C0006142 human GSE3744 sample 24</text></g><g class="point"><path d="M0,262.35V261.92H29.53V262.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.157208333333479,262.264)scale(0.02866666666666712)">Multi-Treatment Models Breast Cancer GSE136823 2/Multi-Treatment Models Breast Cancer GSE136823 7</text></g><g class="point"><path d="M0,261.81V261.39H29.53V261.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.94425000000034,261.726)scale(0.028000000000001062)">Multi-Treatment Models Breast Cancer GSE136823 1/Multi-Treatment Models Breast Cancer GSE136823 7</text></g><g class="point"><path d="M0,261.28V260.85H29.65V261.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.485531249998896,261.19399999999996)scale(0.028666666666663333)">breast cancer DOID-1612 human GSE3744 sample 978/Breast Cancer C0006142 mouse GSE2528 sample 28</text></g><g class="point"><path d="M0,260.75V260.32H29.87V260.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.93389583333349,260.664)scale(0.02866666666666712)">sporadic breast cancer DOID-8029 human GSE3744 sample 979/Breast Cancer C0006142 rat GSE1872 sample 63</text></g><g class="point"><path d="M0,260.21V259.79H30.27V260.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(5.697562499999444,260.126)scale(0.02799999999999727)">Genes with Mutations Associated with Breast Cancer/Breast Cancer</text></g><g class="point"><path d="M0,259.68V259.25H30.5V259.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.497229166666785,259.59400000000005)scale(0.02866666666666712)">Breast cancer/Proteins Involved in Breast Cancer Related to NOTCH Signaling Pathway</text></g><g class="point"><path d="M0,259.15V258.72H31.02V259.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.35160416666558,259.06399999999996)scale(0.028666666666663333)">Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway/WNT Signaling in Breast Cancer</text></g><g class="point"><path d="M0,258.61V258.19H31.05V258.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.881687500000337,258.52599999999995)scale(0.028000000000001062)">Breast Cancer C0006142 human GSE2429 sample 148/Breast Cancer C0006142 rat GSE1872 sample 63</text></g><g class="point"><path d="M0,258.08V257.65H31.23V258.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.349166666666799,257.994)scale(0.02866666666666712)">Genes with Mutations Associated with Breast Cancer/ESR1/ERBB Positive Luminal Breast Cancer</text></g><g class="point"><path d="M0,257.55V257.12H31.23V257.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.105750000000112,257.46400000000006)scale(0.02866666666666712)">Breast cancer pathway WP4262/Proteins with Altered Expression in Breast Cancer</text></g><g class="point"><path d="M0,257.01V256.59H31.66V257.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(5.4158125000002055,256.92599999999993)scale(0.028000000000001062)">Breast cancer/Proteins with Altered Expression in Breast Cancer</text></g><g class="point"><path d="M0,256.48V256.05H31.83V256.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(5.88741666666676,256.394)scale(0.02866666666666712)">Breast cancer pathway WP4262/NOTCH1 Signaling in Breast Cancer</text></g><g class="point"><path d="M0,255.95V255.52H31.92V255.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.619458333332851,255.864)scale(0.028666666666665227)">Breast Cancer C0006142 human GSE2429 sample 148/breast cancer DOID-1612 human GSE9574 sample 448</text></g><g class="point"><path d="M0,255.41V254.99H31.93V255.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.466562499999629,255.326)scale(0.027999999999999168)">Multi-Treatment Models Breast Cancer GSE136823 4/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:40</text></g><g class="point"><path d="M0,254.88V254.45H32.07V254.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.983416666666809,254.79399999999998)scale(0.02866666666666712)">Breast Cancer C0006142 human GSE3744 sample 24/Breast Cancer C0006142 rat GSE1872 sample 63</text></g><g class="point"><path d="M0,254.35V253.92H32.12V254.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.398833333333497,254.26399999999998)scale(0.02866666666666712)">Breast Cancer C0006142 human GSE1379 sample 392/sporadic breast cancer DOID-8029 human GSE3744 sample 979</text></g><g class="point"><path d="M0,253.81V253.39H32.35V253.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.150500000000271,253.726)scale(0.028000000000001062)">Proteins Involved in Breast Cancer Related to WNT Signaling Pathway/Breast Cancer</text></g><g class="point"><path d="M0,253.28V252.85H32.44V253.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.952010416666841,253.194)scale(0.02866666666666712)">estradiol human MCF-7 breast cancer cells GDS3283 ligand:42/estradiol human MCF-7 breast cancer cells GDS3105 ligand:38</text></g><g class="point"><path d="M0,252.75V252.32H32.45V252.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.154520833333478,252.664)scale(0.02866666666666712)">breast cancer DOID-1612 human GSE3744 sample 978/Breast Cancer C0006142 rat GSE1872 sample 63</text></g><g class="point"><path d="M0,252.21V251.79H32.74V252.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.647187500000328,252.126)scale(0.028000000000001062)">Genes with Mutations Associated with Breast Cancer/Hereditary Breast and Ovarian Cancer Syndrome</text></g><g class="point"><path d="M0,251.68V251.25H32.78V251.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.24992708333348,251.594)scale(0.02866666666666712)">Breast cancer DOID-1612 mouse GSE24594 sample 616/Breast Cancer C0006142 rat GSE1872 sample 63</text></g><g class="point"><path d="M0,251.15V250.72H32.9V251.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.053791666666778,251.064)scale(0.02866666666666712)">Breast cancer pathway WP4262/Hereditary Breast and Ovarian Cancer Syndrome</text></g><g class="point"><path d="M0,250.61V250.19H33.19V250.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.002312500000304,250.526)scale(0.028000000000001062)">Proteins with Altered Expression in Breast Cancer/ERBB/VEGFR/Akt Signaling in Breast Cancer</text></g><g class="point"><path d="M0,250.08V249.65H33.44V250.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.556156250000104,249.994)scale(0.02866666666666712)">WNT Signaling in Breast Cancer/ESR1/ERBB Positive Luminal Breast Cancer</text></g><g class="point"><path d="M0,249.55V249.12H33.51V249.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.58138541666682,249.464)scale(0.02866666666666712)">Breast cancer DOID-1612 mouse GSE24594 sample 616/Breast Cancer C0006142 mouse GSE2528 sample 28</text></g><g class="point"><path d="M0,249.01V248.59H33.58V249.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.466562499999629,248.92600000000002)scale(0.027999999999999168)">Multi-Treatment Models Breast Cancer GSE136823 5/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:40</text></g><g class="point"><path d="M0,248.48V248.05H34.02V248.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(13.660562499999314,248.39399999999998)scale(0.028666666666665227)">estradiol human MCF-7 breast cancer cells GDS3283 ligand:43/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:39</text></g><g class="point"><path d="M0,247.95V247.52H34.73V247.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.667833333332847,247.864)scale(0.028666666666665227)">NOTCH1 Signaling in Breast Cancer/Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway</text></g><g class="point"><path d="M0,247.41V246.99H35.49V247.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(4.225812499999875,247.326)scale(0.027999999999999168)">Breast cancer/NOTCH1 Signaling in Breast Cancer</text></g><g class="point"><path d="M0,246.88V246.45H35.95V246.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.091166666666794,246.79399999999998)scale(0.02866666666666712)">Proteins with Altered Expression in Breast Cancer/ESR1/ERBB Positive Luminal Breast Cancer</text></g><g class="point"><path d="M0,246.35V245.92H36.33V246.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.110677083333446,246.26399999999998)scale(0.02866666666666712)">Hereditary Breast and Ovarian Cancer Syndrome/ESR1 Signaling in Breast Cancer</text></g><g class="point"><path d="M0,245.81V245.39H36.92V245.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.712562500000255,245.726)scale(0.028000000000001062)">NOTCH1 Signaling in Breast Cancer/ESR1/ERBB Positive Luminal Breast Cancer</text></g><g class="point"><path d="M0,245.28V244.85H38.44V245.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.388135416666799,245.194)scale(0.02866666666666712)">IGF1R/AKT Signaling in Breast Cancer/Integrated Breast Cancer Pathway Homo sapiens WP1984</text></g><g class="point"><path d="M0,244.75V244.32H38.68V244.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.080218750000112,244.664)scale(0.02866666666666712)">Integrated breast cancer pathway WP1984/IGF1R/AKT Signaling in Breast Cancer</text></g><g class="point"><path d="M0,244.21V243.79H38.68V244.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.161750000000234,244.126)scale(0.028000000000001062)">Integrated breast cancer pathway/IGF1R/AKT Signaling in Breast Cancer</text></g><g class="point"><path d="M0,243.68V243.25H38.76V243.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.113812500000113,243.594)scale(0.02866666666666712)">IGF1R/AKT Signaling in Breast Cancer/Integrated Breast Cancer Pathway WP1984</text></g><g class="point"><path d="M0,243.15V242.72H38.88V243.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.631697916666868,243.064)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway/Proteins Involved in Breast Cancer Related to WNT Signaling Pathway</text></g><g class="point"><path d="M0,242.61V242.19H39.29V242.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.22906250000035,242.526)scale(0.028000000000001062)">Breast Cancer C0006142 human GSE1379 sample 392/Breast Cancer C0006142 human GSE3744 sample 24</text></g><g class="point"><path d="M0,242.08V241.65H39.48V242.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.321593750000147,241.994)scale(0.02866666666666712)">Hereditary Breast and Ovarian Cancer Syndrome/Integrated Breast Cancer Pathway Homo sapiens WP1984</text></g><g class="point"><path d="M0,241.55V241.12H39.71V241.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.013229166666793,241.464)scale(0.02866666666666712)">Integrated breast cancer pathway WP1984/Hereditary Breast and Ovarian Cancer Syndrome</text></g><g class="point"><path d="M0,241.01V240.59H39.71V241.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.07349999999979,240.92600000000002)scale(0.027999999999999168)">Integrated breast cancer pathway/Hereditary Breast and Ovarian Cancer Syndrome</text></g><g class="point"><path d="M0,240.48V240.05H39.78V240.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.046822916666262,240.39399999999998)scale(0.028666666666665227)">Hereditary Breast and Ovarian Cancer Syndrome/Integrated Breast Cancer Pathway WP1984</text></g><g class="point"><path d="M0,239.95V239.52H39.92V239.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.3762916666662965,239.864)scale(0.028666666666665227)">NOTCH1 Signaling in Breast Cancer/Hereditary Breast and Ovarian Cancer Syndrome</text></g><g class="point"><path d="M0,239.41V238.99H40.34V239.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.125437499999818,239.326)scale(0.027999999999999168)">Breast cancer/Integrated Breast Cancer Pathway Homo sapiens WP1984</text></g><g class="point"><path d="M0,238.88V238.45H40.7V238.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(4.191604166666733,238.79399999999998)scale(0.02866666666666712)">Integrated breast cancer pathway/Breast cancer</text></g><g class="point"><path d="M0,238.35V237.92H40.7V238.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(4.963364583333412,238.26399999999998)scale(0.02866666666666712)">Integrated breast cancer pathway WP1984/Breast cancer</text></g><g class="point"><path d="M0,237.81V237.39H40.81V237.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(4.8807500000001856,237.726)scale(0.028000000000001062)">Breast cancer/Integrated Breast Cancer Pathway WP1984</text></g><g class="point"><path d="M0,237.28V236.85H40.84V237.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.907718750000141,237.194)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to ESR1 Signaling Pathway/WNT Signaling in Breast Cancer</text></g><g class="point"><path d="M0,236.75V236.32H40.84V236.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.22439583333348,236.664)scale(0.02866666666666712)">NOTCH1 Signaling in Breast Cancer/Proteins Involved in Breast Cancer Related to ESR1 Signaling Pathway</text></g><g class="point"><path d="M0,236.21V235.79H41.13V236.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.71193750000033,236.126)scale(0.028000000000001062)">ERBB/VEGFR/Akt Signaling in Breast Cancer/Integrated Breast Cancer Pathway Homo sapiens WP1984</text></g><g class="point"><path d="M0,235.68V235.25H41.4V235.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.8396875000001085,235.594)scale(0.02866666666666712)">Integrated breast cancer pathway/ERBB/VEGFR/Akt Signaling in Breast Cancer</text></g><g class="point"><path d="M0,235.15V234.72H41.4V235.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.611447916666787,235.064)scale(0.02866666666666712)">Integrated breast cancer pathway WP1984/ERBB/VEGFR/Akt Signaling in Breast Cancer</text></g><g class="point"><path d="M0,234.61V234.19H41.49V234.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.467250000000283,234.526)scale(0.028000000000001062)">ERBB/VEGFR/Akt Signaling in Breast Cancer/Integrated Breast Cancer Pathway WP1984</text></g><g class="point"><path d="M0,234.08V233.65H41.58V234.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(5.5711875000000886,233.994)scale(0.02866666666666712)">Breast cancer pathway WP4262/WNT Signaling in Breast Cancer</text></g><g class="point"><path d="M0,233.55V233.12H41.63V233.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.681270833333487,233.464)scale(0.02866666666666712)">breast cancer DOID-1612 human GSE9574 sample 448/breast cancer DOID-1612 human GSE3744 sample 978</text></g><g class="point"><path d="M0,233.01V232.59H42.15V233.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(3.9164999999998837,232.92600000000002)scale(0.027999999999999168)">Breast cancer/WNT Signaling in Breast Cancer</text></g><g class="point"><path d="M0,232.48V232.05H42.36V232.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(4.040208333333131,232.39399999999998)scale(0.028666666666665227)">Breast Cancer/WNT Signaling in Breast Cancer</text></g><g class="point"><path d="M0,231.95V231.52H42.76V231.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.619458333332851,231.864)scale(0.028666666666665227)">Breast Cancer C0006142 human GSE1379 sample 392/breast cancer DOID-1612 human GSE3744 sample 978</text></g><g class="point"><path d="M0,231.41V230.99H43.6V231.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.960437499999733,231.326)scale(0.027999999999999168)">NOTCH1 Signaling in Breast Cancer/Proteins Involved in Breast Cancer Related to WNT Signaling Pathway</text></g><g class="point"><path d="M0,230.88V230.45H43.87V230.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(11.61313541666685,230.79399999999998)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway/Integrated Breast Cancer Pathway Homo sapiens WP1984</text></g><g class="point"><path d="M0,230.35V229.92H43.96V230.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.839083333333537,230.26399999999998)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway/Proteins Involved in Breast Cancer Related to NOTCH Signaling Pathway</text></g><g class="point"><path d="M0,229.81V229.39H44.14V229.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.352625000000279,229.726)scale(0.028000000000001062)">Proteins Involved in Breast Cancer Related to NOTCH Signaling Pathway/Breast Cancer</text></g><g class="point"><path d="M0,229.28V228.85H44.15V229.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.304770833333496,229.194)scale(0.02866666666666712)">Integrated breast cancer pathway WP1984/Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway</text></g><g class="point"><path d="M0,228.75V228.32H44.15V228.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.533458333333485,228.664)scale(0.02866666666666712)">Integrated breast cancer pathway/Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway</text></g><g class="point"><path d="M0,228.21V227.79H44.24V228.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.097937500000382,228.126)scale(0.028000000000001062)">Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway/Integrated Breast Cancer Pathway WP1984</text></g><g class="point"><path d="M0,227.68V227.25H44.42V227.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.76338541666687,227.594)scale(0.02866666666666712)">Multi-Treatment Models Breast Cancer GSE136823 7/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:39</text></g><g class="point"><path d="M0,227.15V226.72H44.48V227.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.510166666666818,227.064)scale(0.02866666666666712)">breast cancer DOID-1612 human GSE9574 sample 448/Breast Cancer C0006142 human GSE3744 sample 24</text></g><g class="point"><path d="M0,226.61V226.19H44.62V226.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.853687500000335,226.526)scale(0.028000000000001062)">Proteins Involved in Breast Cancer Related to NOTCH Signaling Pathway/WNT Signaling in Breast Cancer</text></g><g class="point"><path d="M0,226.08V225.65H45.49V226.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.85128125000014,225.994)scale(0.02866666666666712)">Breast cancer pathway WP4262/Proteins Involved in Breast Cancer Related to WNT Signaling Pathway</text></g><g class="point"><path d="M0,225.55V225.12H45.7V225.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(5.575218750000088,225.464)scale(0.02866666666666712)">Breast Cancer/Proteins with Altered Expression in Breast Cancer</text></g><g class="point"><path d="M0,225.01V224.59H45.79V225.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.946624999999794,224.92600000000002)scale(0.027999999999999168)">WNT Signaling in Breast Cancer/Proteins with Altered Expression in Breast Cancer</text></g><g class="point"><path d="M0,224.48V224.05H45.79V224.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.428249999999627,224.39399999999998)scale(0.028666666666665227)">NOTCH1 Signaling in Breast Cancer/Proteins with Altered Expression in Breast Cancer</text></g><g class="point"><path d="M0,223.95V223.52H45.85V223.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.763385416666026,223.864)scale(0.028666666666665227)">Multi-Treatment Models Breast Cancer GSE136823 7/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:40</text></g><g class="point"><path d="M0,223.41V222.99H46.09V223.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.120749999999789,223.326)scale(0.027999999999999168)">Breast cancer/Proteins Involved in Breast Cancer Related to WNT Signaling Pathway</text></g><g class="point"><path d="M0,222.88V222.45H46.1V222.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.392562500000166,222.79399999999998)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to WNT Signaling Pathway/Proteins with Altered Expression in Breast Cancer</text></g><g class="point"><path d="M0,222.35V221.92H46.34V222.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.39564583333353,222.26399999999998)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to ESR1 Signaling Pathway/Proteins Involved in Breast Cancer Related to NOTCH Signaling Pathway</text></g><g class="point"><path d="M0,221.81V221.39H47.14V221.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.353000000000392,221.726)scale(0.028000000000001062)">Proteins Involved in Breast Cancer Related to NOTCH Signaling Pathway/Proteins with Altered Expression in Breast Cancer</text></g><g class="point"><path d="M0,221.28V220.85H47.23V221.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.364343750000165,221.194)scale(0.02866666666666712)">NOTCH1 Signaling in Breast Cancer/Proteins Involved in Breast Cancer Related to ERBB2/VEGFR/Akt Signaling Pathway</text></g><g class="point"><path d="M0,220.75V220.32H47.23V220.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.047666666666826,220.664)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to ERBB2/VEGFR/Akt Signaling Pathway/WNT Signaling in Breast Cancer</text></g><g class="point"><path d="M0,220.21V219.79H48.07V220.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.820562500000372,220.126)scale(0.028000000000001062)">Multi-Treatment Models Breast Cancer GSE136823 1/estradiol human MCF-7 breast cancer cells GDS3283 ligand:42</text></g><g class="point"><path d="M0,219.68V219.25H48.08V219.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.309197916666863,219.594)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to ERBB2/VEGFR/Akt Signaling Pathway/Integrated Breast Cancer Pathway Homo sapiens WP1984</text></g><g class="point"><path d="M0,219.15V218.72H48.28V219.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.889156250000125,219.064)scale(0.02866666666666712)">ESR1 Signaling in Breast Cancer/Integrated Breast Cancer Pathway Homo sapiens WP1984</text></g><g class="point"><path d="M0,218.61V218.19H48.41V218.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.745437500000408,218.526)scale(0.028000000000001062)">Integrated breast cancer pathway WP1984/Proteins Involved in Breast Cancer Related to ERBB2/VEGFR/Akt Signaling Pathway</text></g><g class="point"><path d="M0,218.08V217.65H48.41V218.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.229520833333495,217.994)scale(0.02866666666666712)">Integrated breast cancer pathway/Proteins Involved in Breast Cancer Related to ERBB2/VEGFR/Akt Signaling Pathway</text></g><g class="point"><path d="M0,217.55V217.12H48.51V217.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(11.034875000000175,217.464)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to ERBB2/VEGFR/Akt Signaling Pathway/Integrated Breast Cancer Pathway WP1984</text></g><g class="point"><path d="M0,217.01V216.59H48.58V217.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(5.674374999999832,216.92600000000002)scale(0.027999999999999168)">Integrated breast cancer pathway/ESR1 Signaling in Breast Cancer</text></g><g class="point"><path d="M0,216.48V216.05H48.58V216.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.580791666666336,216.39399999999998)scale(0.028666666666665227)">Integrated breast cancer pathway WP1984/ESR1 Signaling in Breast Cancer</text></g><g class="point"><path d="M0,215.95V215.52H48.68V215.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.614385416666335,215.864)scale(0.028666666666665227)">ESR1 Signaling in Breast Cancer/Integrated Breast Cancer Pathway WP1984</text></g><g class="point"><path d="M0,215.41V214.99H49.1V215.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(11.904812499999647,215.326)scale(0.027999999999999168)">Proteins Involved in Breast Cancer Related to ESR1 Signaling Pathway/Proteins Involved in Breast Cancer Related to WNT Signaling Pathway</text></g><g class="point"><path d="M0,214.88V214.45H49.1V214.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.832718750000124,214.79399999999998)scale(0.02866666666666712)">Breast cancer pathway WP4262/Integrated Breast Cancer Pathway Homo sapiens WP1984</text></g><g class="point"><path d="M0,214.35V213.92H49.51V214.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(5.752593750000091,214.26399999999998)scale(0.02866666666666712)">Integrated breast cancer pathway/Breast cancer pathway WP4262</text></g><g class="point"><path d="M0,213.81V213.39H50.87V213.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.22906250000035,213.726)scale(0.028000000000001062)">Breast Cancer C0006142 human GSE2429 sample 148/Breast Cancer C0006142 human GSE3744 sample 24</text></g><g class="point"><path d="M0,213.28V212.85H51.37V213.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.619458333333485,213.194)scale(0.02866666666666712)">Breast Cancer C0006142 human GSE2429 sample 148/breast cancer DOID-1612 human GSE3744 sample 978</text></g><g class="point"><path d="M0,212.75V212.32H51.61V212.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(5.621354166666756,212.664)scale(0.02866666666666712)">Breast cancer pathway WP4262/ESR1 Signaling in Breast Cancer</text></g><g class="point"><path d="M0,212.21V211.79H52.03V212.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.372625000000242,212.126)scale(0.028000000000001062)">Integrated breast cancer pathway WP1984/Breast cancer pathway WP4262</text></g><g class="point"><path d="M0,211.68V211.25H52.11V211.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(5.893239583333426,211.594)scale(0.02866666666666712)">NOTCH1 Signaling in Breast Cancer/WNT Signaling in Breast Cancer</text></g><g class="point"><path d="M0,211.15V210.72H52.17V211.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.5579479166667705,211.064)scale(0.02866666666666712)">Breast cancer pathway WP4262/Integrated Breast Cancer Pathway WP1984</text></g><g class="point"><path d="M0,210.61V210.19H52.35V210.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(3.9659375000001504,210.526)scale(0.028000000000001062)">Breast cancer/ESR1 Signaling in Breast Cancer</text></g><g class="point"><path d="M0,210.08V209.65H54.13V210.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.345031250000195,209.994)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to NOTCH Signaling Pathway/Proteins Involved in Breast Cancer Related to WNT Signaling Pathway</text></g><g class="point"><path d="M0,209.55V209.12H54.82V209.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.76338541666687,209.464)scale(0.02866666666666712)">Multi-Treatment Models Breast Cancer GSE136823 1/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:41</text></g><g class="point"><path d="M0,209.01V208.59H55.01V209.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(5.978437499999822,208.92600000000002)scale(0.027999999999999168)">Breast cancer pathway WP4262/IGF1R/AKT Signaling in Breast Cancer</text></g><g class="point"><path d="M0,208.48V208.05H55.73V208.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(13.328208333332665,208.39399999999998)scale(0.028666666666665227)">Proteins Involved in Breast Cancer Related to ERBB2/VEGFR/Akt Signaling Pathway/Proteins Involved in Breast Cancer Related to WNT Signaling Pathway</text></g><g class="point"><path d="M0,207.95V207.52H55.77V207.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(4.559343749999771,207.864)scale(0.028666666666665227)">Breast cancer/IGF1R/AKT Signaling in Breast Cancer</text></g><g class="point"><path d="M0,207.41V206.99H56.46V207.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.697312499999683,207.326)scale(0.027999999999999168)">estradiol human MCF-7 breast cancer cells GDS3283 ligand:43/estradiol human MCF-7 breast cancer cells GDS3105 ligand:38</text></g><g class="point"><path d="M0,206.88V206.45H56.5V206.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(11.169250000000178,206.79399999999998)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to ESR1 Signaling Pathway/Integrated Breast Cancer Pathway Homo sapiens WP1984</text></g><g class="point"><path d="M0,206.35V205.92H56.62V206.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.345333333333482,206.26399999999998)scale(0.02866666666666712)">Breast cancer pathway WP4262/Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway</text></g><g class="point"><path d="M0,205.81V205.39H56.82V205.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.466562500000473,205.726)scale(0.028000000000001062)">Multi-Treatment Models Breast Cancer GSE136823 2/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:41</text></g><g class="point"><path d="M0,205.28V204.85H56.86V205.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.08957291666681,205.194)scale(0.02866666666666712)">Integrated breast cancer pathway/Proteins Involved in Breast Cancer Related to ESR1 Signaling Pathway</text></g><g class="point"><path d="M0,204.75V204.32H56.86V204.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.861333333333489,204.664)scale(0.02866666666666712)">Integrated breast cancer pathway WP1984/Proteins Involved in Breast Cancer Related to ESR1 Signaling Pathway</text></g><g class="point"><path d="M0,204.21V203.79H56.98V204.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.664812500000366,204.126)scale(0.028000000000001062)">Proteins Involved in Breast Cancer Related to ESR1 Signaling Pathway/Integrated Breast Cancer Pathway WP1984</text></g><g class="point"><path d="M0,203.68V203.25H57V203.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.652010416666772,203.594)scale(0.02866666666666712)">Breast cancer pathway WP4262/ERBB/VEGFR/Akt Signaling in Breast Cancer</text></g><g class="point"><path d="M0,203.15V202.72H57.35V203.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(13.535145833333548,203.064)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to ERBB2/VEGFR/Akt Signaling Pathway/Proteins Involved in Breast Cancer Related to NOTCH Signaling Pathway</text></g><g class="point"><path d="M0,202.61V202.19H57.44V202.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.603312500000288,202.526)scale(0.028000000000001062)">Breast cancer/Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway</text></g><g class="point"><path d="M0,202.08V201.65H57.83V202.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(5.090572916666748,201.994)scale(0.02866666666666712)">Breast cancer/ERBB/VEGFR/Akt Signaling in Breast Cancer</text></g><g class="point"><path d="M0,201.55V201.12H59.67V201.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.054385416666825,201.464)scale(0.02866666666666712)">Multi-Treatment Models Breast Cancer GSE136823 2/estradiol human MCF-7 breast cancer cells GDS3283 ligand:42</text></g><g class="point"><path d="M0,201.01V200.59H60.31V201.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.808312499999708,200.92600000000002)scale(0.027999999999999168)">Breast cancer pathway WP4262/Proteins Involved in Breast Cancer Related to ERBB2/VEGFR/Akt Signaling Pathway</text></g><g class="point"><path d="M0,200.48V200.05H61.25V200.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.480406249999573,200.39399999999998)scale(0.028666666666665227)">Breast cancer/Proteins Involved in Breast Cancer Related to ERBB2/VEGFR/Akt Signaling Pathway</text></g><g class="point"><path d="M0,199.95V199.52H63.04V199.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.901895833332887,199.864)scale(0.028666666666665227)">Breast cancer pathway WP4262/Proteins Involved in Breast Cancer Related to ESR1 Signaling Pathway</text></g><g class="point"><path d="M0,199.41V198.99H63.76V199.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(11.313312499999665,199.326)scale(0.027999999999999168)">Proteins Involved in Breast Cancer Related to ERBB2/VEGFR/Akt Signaling Pathway/Proteins with Altered Expression in Breast Cancer</text></g><g class="point"><path d="M0,198.88V198.45H63.98V198.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.340906250000116,198.79399999999998)scale(0.02866666666666712)">Breast cancer/Proteins Involved in Breast Cancer Related to ESR1 Signaling Pathway</text></g><g class="point"><path d="M0,198.35V197.92H65.29V198.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.76338541666687,198.26399999999998)scale(0.02866666666666712)">Multi-Treatment Models Breast Cancer GSE136823 2/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:40</text></g><g class="point"><path d="M0,197.81V197.39H65.29V197.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.466562500000473,197.726)scale(0.028000000000001062)">Multi-Treatment Models Breast Cancer GSE136823 1/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:40</text></g><g class="point"><path d="M0,197.28V196.85H65.45V197.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.3017395833334335,197.194)scale(0.02866666666666712)">Breast Cancer/Integrated Breast Cancer Pathway Homo sapiens WP1984</text></g><g class="point"><path d="M0,196.75V196.32H65.92V196.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(4.222062500000067,196.664)scale(0.02866666666666712)">Integrated breast cancer pathway/Breast Cancer</text></g><g class="point"><path d="M0,196.21V195.79H68.2V196.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(13.342875000000506,196.126)scale(0.028000000000001062)">estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:41/estradiol human MCF-7 breast cancer cells GDS3105 ligand:38</text></g><g class="point"><path d="M0,195.68V195.25H68.36V195.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.76338541666687,195.594)scale(0.02866666666666712)">Multi-Treatment Models Breast Cancer GSE136823 2/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:39</text></g><g class="point"><path d="M0,195.15V194.72H68.87V195.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(4.993822916666746,195.064)scale(0.02866666666666712)">Integrated breast cancer pathway WP1984/Breast Cancer</text></g><g class="point"><path d="M0,194.61V194.19H69.03V194.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(4.910500000000186,194.526)scale(0.028000000000001062)">Breast Cancer/Integrated Breast Cancer Pathway WP1984</text></g><g class="point"><path d="M0,194.08V193.65H72.33V194.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.76338541666687,193.994)scale(0.02866666666666712)">Multi-Treatment Models Breast Cancer GSE136823 1/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:39</text></g><g class="point"><path d="M0,193.55V193.12H72.42V193.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.81768750000014,193.464)scale(0.02866666666666712)">ESR1/ERBB Positive Luminal Breast Cancer/Integrated Breast Cancer Pathway Homo sapiens WP1984</text></g><g class="point"><path d="M0,193.01V192.59H72.91V193.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.581312499999805,192.92600000000002)scale(0.027999999999999168)">Integrated breast cancer pathway/ESR1/ERBB Positive Luminal Breast Cancer</text></g><g class="point"><path d="M0,192.48V192.05H73.55V192.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.988989583332831,192.39399999999998)scale(0.028666666666665227)">Proteins Involved in Breast Cancer Related to ESR1 Signaling Pathway/ERBB/VEGFR/Akt Signaling in Breast Cancer</text></g><g class="point"><path d="M0,191.95V191.52H76.05V191.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.509770833332956,191.864)scale(0.028666666666665227)">Integrated breast cancer pathway WP1984/ESR1/ERBB Positive Luminal Breast Cancer</text></g><g class="point"><path d="M0,191.41V190.99H76.22V191.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.367937499999781,191.326)scale(0.027999999999999168)">ESR1/ERBB Positive Luminal Breast Cancer/Integrated Breast Cancer Pathway WP1984</text></g><g class="point"><path d="M0,190.88V190.45H76.52V190.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.09828125000016,190.79399999999998)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to ERBB2/VEGFR/Akt Signaling Pathway/ESR1 Signaling in Breast Cancer</text></g><g class="point"><path d="M0,190.35V189.92H78.07V190.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(4.356885416666736,190.26399999999998)scale(0.02866666666666712)">NOTCH1 Signaling in Breast Cancer/Breast Cancer</text></g><g class="point"><path d="M0,189.81V189.39H78.69V189.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.23781250000035,189.726)scale(0.028000000000001062)">Proteins Involved in Breast Cancer Related to ESR1 Signaling Pathway/IGF1R/AKT Signaling in Breast Cancer</text></g><g class="point"><path d="M0,189.28V188.85H80.58V189.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.398833333333497,189.194)scale(0.02866666666666712)">Breast Cancer C0006142 human GSE2429 sample 148/sporadic breast cancer DOID-8029 human GSE3744 sample 979</text></g><g class="point"><path d="M0,188.75V188.32H80.66V188.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.597260416666835,188.664)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to ERBB2/VEGFR/Akt Signaling Pathway/IGF1R/AKT Signaling in Breast Cancer</text></g><g class="point"><path d="M0,188.21V187.79H82.38V188.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.183562500000349,188.126)scale(0.028000000000001062)">Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway/ESR1 Signaling in Breast Cancer</text></g><g class="point"><path d="M0,187.68V187.25H83.36V187.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(4.988895833333412,187.594)scale(0.02866666666666712)">Breast cancer/ESR1/ERBB Positive Luminal Breast Cancer</text></g><g class="point"><path d="M0,187.15V186.72H85.47V187.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.432427083333499,187.064)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway/ERBB/VEGFR/Akt Signaling in Breast Cancer</text></g><g class="point"><path d="M0,186.61V186.19H88.9V186.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.199937500000273,186.526)scale(0.028000000000001062)">Proteins Involved in Breast Cancer Related to ESR1 Signaling Pathway/Breast Cancer</text></g><g class="point"><path d="M0,186.08V185.65H89.6V186.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.814802083333457,185.994)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway/Breast Cancer</text></g><g class="point"><path d="M0,185.55V185.12H90.33V185.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(5.523260416666754,185.464)scale(0.02866666666666712)">Hereditary Breast and Ovarian Cancer Syndrome/Breast Cancer</text></g><g class="point"><path d="M0,185.01V184.59H94.77V185.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(2.4154374999999284,184.92600000000002)scale(0.027999999999999168)">Breast cancer/Breast Cancer</text></g><g class="point"><path d="M0,184.48V184.05H97.57V184.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.330749999999481,184.39399999999998)scale(0.028666666666665227)">Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway/ESR1/ERBB Positive Luminal Breast Cancer</text></g><g class="point"><path d="M0,183.95V183.52H98.61V183.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.550333333333004,183.864)scale(0.028666666666665227)">Breast cancer pathway WP4262/ESR1/ERBB Positive Luminal Breast Cancer</text></g><g class="point"><path d="M0,183.41V182.99H98.68V183.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.852249999999767,183.326)scale(0.027999999999999168)">Hereditary Breast and Ovarian Cancer Syndrome/ESR1/ERBB Positive Luminal Breast Cancer</text></g><g class="point"><path d="M0,182.88V182.45H100.23V182.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(13.660562500000216,182.79399999999998)scale(0.02866666666666712)">estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:40/estradiol human MCF-7 breast cancer cells GDS3105 ligand:38</text></g><g class="point"><path d="M0,182.35V181.92H101.32V182.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.380718750000149,182.26399999999998)scale(0.02866666666666712)">NOTCH1 Signaling in Breast Cancer/Proteins Involved in Breast Cancer Related to NOTCH Signaling Pathway</text></g><g class="point"><path d="M0,181.81V181.39H106.42V181.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(3.9405625000001496,181.726)scale(0.028000000000001062)">Breast cancer pathway WP4262/Breast Cancer</text></g><g class="point"><path d="M0,181.28V180.85H108.92V181.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(17.14221875000027,181.194)scale(0.02866666666666712)">Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shIL13RA2) GSE57677 ligand:243/Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shSCR) GSE57677 ligand:242</text></g><g class="point"><path d="M0,180.75V180.32H109.22V180.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.887312500000156,180.664)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to ESR1 Signaling Pathway/ESR1/ERBB Positive Luminal Breast Cancer</text></g><g class="point"><path d="M0,180.21V179.79H110.41V180.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.651562500000328,180.126)scale(0.028000000000001062)">Proteins Involved in Breast Cancer Related to WNT Signaling Pathway/WNT Signaling in Breast Cancer</text></g><g class="point"><path d="M0,179.68V179.25H111.12V179.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.901197916666824,179.594)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway/IGF1R/AKT Signaling in Breast Cancer</text></g><g class="point"><path d="M0,179.15V178.72H114.07V179.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.054385416666825,179.064)scale(0.02866666666666712)">Multi-Treatment Models Breast Cancer GSE136823 2/estradiol human MCF-7 breast cancer cells GDS3283 ligand:43</text></g><g class="point"><path d="M0,178.61V178.19H115.02V178.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(13.97025000000053,178.526)scale(0.028000000000001062)">Stathmin and breast cancer resistance to antimicrotubule agents/Stathmin and breast cancer resistance to antimicrotubule agents Homo sapiens h stathminPathway</text></g><g class="point"><path d="M0,178.08V177.65H116.42V178.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(13.660562500000216,177.994)scale(0.02866666666666712)">estradiol human MCF-7 breast cancer cells GDS3105 ligand:38/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:39</text></g><g class="point"><path d="M0,177.55V177.12H121.1V177.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.708447916666773,177.464)scale(0.02866666666666712)">ERBB/VEGFR/Akt Signaling in Breast Cancer/ESR1 Signaling in Breast Cancer</text></g><g class="point"><path d="M0,177.01V176.59H123.23V177.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.820562499999708,176.92600000000002)scale(0.027999999999999168)">Multi-Treatment Models Breast Cancer GSE136823 1/estradiol human MCF-7 breast cancer cells GDS3283 ligand:43</text></g><g class="point"><path d="M0,176.48V176.05H124.65V176.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.510864583332905,176.39399999999998)scale(0.028666666666665227)">Proteins Involved in Breast Cancer Related to ERBB2/VEGFR/Akt Signaling Pathway/Breast Cancer</text></g><g class="point"><path d="M0,175.95V175.52H125.37V175.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.958333333332883,175.864)scale(0.028666666666665227)">Proteins Involved in Breast Cancer Related to ESR1 Signaling Pathway/ESR1 Signaling in Breast Cancer</text></g><g class="point"><path d="M0,175.41V174.99H129.72V175.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.033562499999821,175.326)scale(0.027999999999999168)">IGF1R/AKT Signaling in Breast Cancer/ESR1 Signaling in Breast Cancer</text></g><g class="point"><path d="M0,174.88V174.45H131.54V174.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(4.589802083333406,174.79399999999998)scale(0.02866666666666712)">Breast Cancer/IGF1R/AKT Signaling in Breast Cancer</text></g><g class="point"><path d="M0,174.35V173.92H131.77V174.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.054385416666825,174.26399999999998)scale(0.02866666666666712)">Multi-Treatment Models Breast Cancer GSE136823 1/estradiol human MCF-7 breast cancer cells GDS3105 ligand:38</text></g><g class="point"><path d="M0,173.81V173.39H131.9V173.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(3.9956875000001517,173.726)scale(0.028000000000001062)">Breast Cancer/ESR1 Signaling in Breast Cancer</text></g><g class="point"><path d="M0,173.28V172.85H132.87V173.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.569937500000167,173.194)scale(0.02866666666666712)">breast cancer DOID-1612 human GSE26910 sample 602/sporadic breast cancer DOID-8029 human GSE3744 sample 979</text></g><g class="point"><path d="M0,172.75V172.32H134.57V172.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(11.026812500000174,172.664)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to ERBB2/VEGFR/Akt Signaling Pathway/ESR1/ERBB Positive Luminal Breast Cancer</text></g><g class="point"><path d="M0,172.21V171.79H143.86V172.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.869687500000412,172.126)scale(0.028000000000001062)">Proteins Involved in Breast Cancer Related to ERBB2/VEGFR/Akt Signaling Pathway/ERBB/VEGFR/Akt Signaling in Breast Cancer</text></g><g class="point"><path d="M0,171.68V171.25H148.44V171.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.054385416666825,171.594)scale(0.02866666666666712)">Multi-Treatment Models Breast Cancer GSE136823 2/estradiol human MCF-7 breast cancer cells GDS3105 ligand:38</text></g><g class="point"><path d="M0,171.15V170.72H154.46V171.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.959229166666809,171.064)scale(0.02866666666666712)">Breast Cancer C0006142 mouse GSE2528 sample 28/Breast Cancer C0006142 rat GSE1872 sample 63</text></g><g class="point"><path d="M0,170.61V170.19H159.7V170.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.940500000000263,170.526)scale(0.028000000000001062)">IGF1R/AKT Signaling in Breast Cancer/ESR1/ERBB Positive Luminal Breast Cancer</text></g><g class="point"><path d="M0,170.08V169.65H163.31V170.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.207427083333448,169.994)scale(0.02866666666666712)">IGF1R/AKT Signaling in Breast Cancer/ERBB/VEGFR/Akt Signaling in Breast Cancer</text></g><g class="point"><path d="M0,169.55V169.12H166.82V169.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.790562500000155,169.464)scale(0.02866666666666712)">breast cancer DOID-1612 human GSE26910 sample 602/breast cancer DOID-1612 human GSE3744 sample 978</text></g><g class="point"><path d="M0,169.01V168.59H169.55V169.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(13.500812499999599,168.92600000000002)scale(0.027999999999999168)">Proteins Involved in Breast Cancer Related to ERBB2/VEGFR/Akt Signaling Pathway/Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway</text></g><g class="point"><path d="M0,168.48V168.05H169.74V168.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.682312499999362,168.39399999999998)scale(0.028666666666665227)">Proteins Involved in Breast Cancer Related to ESR1 Signaling Pathway/Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway</text></g><g class="point"><path d="M0,167.95V167.52H171.27V167.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(13.378822916665994,167.864)scale(0.028666666666665227)">Proteins Involved in Breast Cancer Related to ERBB2/VEGFR/Akt Signaling Pathway/Proteins Involved in Breast Cancer Related to ESR1 Signaling Pathway</text></g><g class="point"><path d="M0,167.41V166.99H174.79V167.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.39574999999972,167.326)scale(0.027999999999999168)">breast cancer DOID-1612 human GSE26910 sample 602/Breast Cancer C0006142 human GSE3744 sample 24</text></g><g class="point"><path d="M0,166.88V166.45H179.82V166.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(5.121031250000081,166.79399999999998)scale(0.02866666666666712)">Breast Cancer/ERBB/VEGFR/Akt Signaling in Breast Cancer</text></g><g class="point"><path d="M0,166.35V165.92H192.95V166.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.606770833333438,166.26399999999998)scale(0.02866666666666712)">ESR1 Signaling in Breast Cancer/ESR1/ERBB Positive Luminal Breast Cancer</text></g><g class="point"><path d="M0,165.81V165.39H212.73V165.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.459375000000283,165.726)scale(0.028000000000001062)">ERBB/VEGFR/Akt Signaling in Breast Cancer/ESR1/ERBB Positive Luminal Breast Cancer</text></g><g class="point"><path d="M0,165.28V164.85H220.98V165.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.952010416666841,165.194)scale(0.02866666666666712)">estradiol human MCF-7 breast cancer cells GDS3283 ligand:43/estradiol human MCF-7 breast cancer cells GDS3283 ligand:42</text></g><g class="point"><path d="M0,164.75V164.32H258.29V164.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(5.019354166666746,164.664)scale(0.02866666666666712)">Breast Cancer/ESR1/ERBB Positive Luminal Breast Cancer</text></g><g class="point"><path d="M0,164.21V163.79H294.3V164.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.22906250000035,164.126)scale(0.028000000000001062)">Breast Cancer C0006142 human GSE1379 sample 392/Breast Cancer C0006142 human GSE1378 sample 52</text></g><g class="point"><path d="M0,163.68V163.25H326.76V163.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(16.36956250000026,163.594)scale(0.02866666666666712)">estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:41/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:39</text></g><g class="point"><path d="M0,163.15V162.72H414.74V163.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.157208333333479,163.064)scale(0.02866666666666712)">Multi-Treatment Models Breast Cancer GSE136823 1/Multi-Treatment Models Breast Cancer GSE136823 2</text></g><g class="point"><path d="M0,162.61V162.19H460.97V162.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.94425000000034,162.526)scale(0.028000000000001062)">Multi-Treatment Models Breast Cancer GSE136823 3/Multi-Treatment Models Breast Cancer GSE136823 7</text></g><g class="point"><path d="M0,162.08V161.65H460.97V162.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.157208333333479,161.994)scale(0.02866666666666712)">Multi-Treatment Models Breast Cancer GSE136823 4/Multi-Treatment Models Breast Cancer GSE136823 5</text></g><g class="point"><path d="M0,161.55V161.12H465.2V161.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(16.36956250000026,161.464)scale(0.02866666666666712)">estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:40/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:39</text></g><g class="point"><path d="M0,161.01V160.59H469.64V161.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.944249999999734,160.92600000000002)scale(0.027999999999999168)">Multi-Treatment Models Breast Cancer GSE136823 3/Multi-Treatment Models Breast Cancer GSE136823 5</text></g><g class="point"><path d="M0,160.48V160.05H505.23V160.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.157208333332873,160.39399999999998)scale(0.028666666666665227)">Multi-Treatment Models Breast Cancer GSE136823 5/Multi-Treatment Models Breast Cancer GSE136823 7</text></g><g class="point"><path d="M0,159.95V159.52H509.78V159.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.157208333332873,159.864)scale(0.028666666666665227)">Multi-Treatment Models Breast Cancer GSE136823 6/Multi-Treatment Models Breast Cancer GSE136823 7</text></g><g class="point"><path d="M0,159.41V158.99H513V159.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(11.161499999999668,159.326)scale(0.027999999999999168)">Breast cancer pathway WP4262/Stathmin and breast cancer resistance to antimicrotubule agents Homo sapiens h stathminPathway</text></g><g class="point"><path d="M0,158.88V158.45H513V158.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.656833333333502,158.79399999999998)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to NOTCH Signaling Pathway/IRF1-19129219-H3396 breast cancer cells-human</text></g><g class="point"><path d="M0,158.35V157.92H513V158.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.833614583333458,158.26399999999998)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to NOTCH Signaling Pathway/breast cancer cell</text></g><g class="point"><path d="M0,157.81V157.39H513V157.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.79793750000041,157.726)scale(0.028000000000001062)">Proteins Involved in Breast Cancer Related to NOTCH Signaling Pathway/Breast Cancer C0006142 human GSE1379 sample 392</text></g><g class="point"><path d="M0,157.28V156.85H513V157.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.403416666666768,157.194)scale(0.02866666666666712)">Hereditary Breast and Ovarian Cancer Syndrome/Cancer Stem cell:Breast</text></g><g class="point"><path d="M0,156.75V156.32H513V156.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(14.87889583333357,156.664)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to ESR1 Signaling Pathway/Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shIL13RA2) GSE57677 ligand:243</text></g><g class="point"><path d="M0,156.21V155.79H513V156.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(14.124687500000535,156.126)scale(0.028000000000001062)">Proteins Involved in Breast Cancer Related to NOTCH Signaling Pathway/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:41</text></g><g class="point"><path d="M0,155.68V155.25H513V155.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(15.322333333333576,155.594)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway/Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shIL13RA2) GSE57677 ligand:243</text></g><g class="point"><path d="M0,155.15V154.72H513V155.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.221260416666812,155.064)scale(0.02866666666666712)">Hereditary Breast and Ovarian Cancer Syndrome/breast cancer DOID-1612 human GSE14943 sample 504</text></g><g class="point"><path d="M0,154.61V154.19H513V154.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.727750000000484,154.526)scale(0.028000000000001062)">Hereditary Breast and Ovarian Cancer Syndrome/Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shIL13RA2) GSE57677 ligand:243</text></g><g class="point"><path d="M0,154.08V153.65H513V154.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(14.763781250000234,153.994)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to ESR1 Signaling Pathway/Stathmin and breast cancer resistance to antimicrotubule agents Homo sapiens h stathminPathway</text></g><g class="point"><path d="M0,153.55V153.12H513V153.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.45611458333353,153.464)scale(0.02866666666666712)">Hereditary Breast and Ovarian Cancer Syndrome/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:41</text></g><g class="point"><path d="M0,153.01V152.59H513V153.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.38556249999975,152.92600000000002)scale(0.027999999999999168)">Hereditary Breast and Ovarian Cancer Syndrome/Breast Cancer C0006142 rat GSE1872 sample 63</text></g><g class="point"><path d="M0,152.48V152.05H513V152.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.916677083332885,152.39399999999998)scale(0.028666666666665227)">Hereditary Breast and Ovarian Cancer Syndrome/Breast Cancer C0006142 mouse GSE2528 sample 28</text></g><g class="point"><path d="M0,151.95V151.52H513V151.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.941312499999551,151.864)scale(0.028666666666665227)">Hereditary Breast and Ovarian Cancer Syndrome/Breast Cancer C0006142 human GSE1378 sample 52</text></g><g class="point"><path d="M0,151.41V150.99H513V151.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.360249999999633,151.326)scale(0.027999999999999168)">Hereditary Breast and Ovarian Cancer Syndrome/Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shSCR) GSE57677 ligand:242</text></g><g class="point"><path d="M0,150.88V150.45H513V150.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(14.747656250000233,150.79399999999998)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:41</text></g><g class="point"><path d="M0,150.35V149.92H513V150.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(11.232406250000178,150.26399999999998)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway/Breast Cancer C0006142 human GSE1378 sample 52</text></g><g class="point"><path d="M0,149.81V149.39H513V149.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(11.07837500000042,149.726)scale(0.028000000000001062)">Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway/Breast Cancer C0006142 human GSE1379 sample 392</text></g><g class="point"><path d="M0,149.28V148.85H513V149.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.857500000000172,149.194)scale(0.02866666666666712)">Genes with Mutations Associated with Breast Cancer/Proteins Involved in Breast Cancer Related to NOTCH Signaling Pathway</text></g><g class="point"><path d="M0,148.75V148.32H513V148.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.007854166666794,148.664)scale(0.02866666666666712)">IGF1R/AKT Signaling in Breast Cancer/Breast Cancer C0006142 human GSE1378 sample 52</text></g><g class="point"><path d="M0,148.21V147.79H513V148.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(5.759687500000219,148.126)scale(0.028000000000001062)">Breast Cancer/Breast Cancer C0006142 mouse GSE2528 sample 28</text></g><g class="point"><path d="M0,147.68V147.25H513V147.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.237531250000194,147.594)scale(0.02866666666666712)">Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome/IRF1-19129219-H3396 breast cancer cells-human</text></g><g class="point"><path d="M0,147.15V146.72H513V147.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.448156250000133,147.064)scale(0.02866666666666712)">ERBB/VEGFR/Akt Signaling in Breast Cancer/Multi-Treatment Models Breast Cancer GSE136823 3</text></g><g class="point"><path d="M0,146.61V146.19H513V146.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.882375000000414,146.526)scale(0.028000000000001062)">Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway/Multi-Treatment Models Breast Cancer GSE136823 6</text></g><g class="point"><path d="M0,146.08V145.65H513V146.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.916125000000205,145.994)scale(0.02866666666666712)">Hereditary Breast and Ovarian Cancer Syndrome/Stathmin and breast cancer resistance to antimicrotubule agents Homo sapiens h stathminPathway</text></g><g class="point"><path d="M0,145.55V145.12H513V145.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.69495833333347,145.464)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway/Cancer Stem cell:Breast</text></g><g class="point"><path d="M0,145.01V144.59H513V145.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.688999999999682,144.92600000000002)scale(0.027999999999999168)">Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway/IRF1-19129219-H3396 breast cancer cells-human</text></g><g class="point"><path d="M0,144.48V144.05H513V144.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.120281249999593,144.39399999999998)scale(0.028666666666665227)">Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway/breast cancer cell</text></g><g class="point"><path d="M0,143.95V143.52H513V143.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(11.141479166666107,143.864)scale(0.028666666666665227)">Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway/Multi-Treatment Models Breast Cancer GSE136823 3</text></g><g class="point"><path d="M0,143.41V142.99H513V143.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.882374999999676,143.326)scale(0.027999999999999168)">Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway/Multi-Treatment Models Breast Cancer GSE136823 4</text></g><g class="point"><path d="M0,142.88V142.45H513V142.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(11.141479166666842,142.79399999999998)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway/Multi-Treatment Models Breast Cancer GSE136823 5</text></g><g class="point"><path d="M0,142.35V141.92H513V142.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(11.141479166666842,142.26399999999998)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway/Multi-Treatment Models Breast Cancer GSE136823 7</text></g><g class="point"><path d="M0,141.81V141.39H513V141.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(14.854000000000564,141.726)scale(0.028000000000001062)">Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway/Stathmin and breast cancer resistance to antimicrotubule agents Homo sapiens h stathminPathway</text></g><g class="point"><path d="M0,141.28V140.85H513V141.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.05060416666681,141.194)scale(0.02866666666666712)">Hereditary Breast and Ovarian Cancer Syndrome/Breast Cancer C0006142 human GSE1379 sample 392</text></g><g class="point"><path d="M0,140.75V140.32H513V140.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.84993750000014,140.664)scale(0.02866666666666712)">Hereditary Breast and Ovarian Cancer Syndrome/Multi-Treatment Models Breast Cancer GSE136823 1</text></g><g class="point"><path d="M0,140.21V139.79H513V140.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.840125000000336,140.126)scale(0.028000000000001062)">Hereditary Breast and Ovarian Cancer Syndrome/Breast Cancer C0006142 human GSE2429 sample 148</text></g><g class="point"><path d="M0,139.68V139.25H513V139.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.251520833333464,139.594)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to ESR1 Signaling Pathway/Cancer Stem cell:Breast</text></g><g class="point"><path d="M0,139.15V138.72H513V139.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.330697916666862,139.064)scale(0.02866666666666712)">Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome/Differentially Breast Cancer Diabetes GSE150586 1</text></g><g class="point"><path d="M0,138.61V138.19H513V138.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.666125000000367,138.526)scale(0.028000000000001062)">Breast Cancer/Stathmin and breast cancer resistance to antimicrotubule agents Homo sapiens h stathminPathway</text></g><g class="point"><path d="M0,138.08V137.65H513V138.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.7120312500001065,137.994)scale(0.02866666666666712)">Integrated breast cancer pathway/Integrated breast cancer pathway WP1984</text></g><g class="point"><path d="M0,137.55V137.12H513V137.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.435510416666864,137.464)scale(0.02866666666666712)">Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome/Multi-Treatment Models Breast Cancer GSE136823 2</text></g><g class="point"><path d="M0,137.01V136.59H513V137.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.14631249999964,136.92600000000002)scale(0.027999999999999168)">Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome/Multi-Treatment Models Breast Cancer GSE136823 1</text></g><g class="point"><path d="M0,136.48V136.05H513V136.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.470447916666041,136.39399999999998)scale(0.028666666666665227)">Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome/Control Nrde2-Depleted Breast Cancer GSE119827 1</text></g><g class="point"><path d="M0,135.95V135.52H513V135.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.502249999999371,135.864)scale(0.028666666666665227)">Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome/Breast Cancer C0006142 mouse GSE2528 sample 28</text></g><g class="point"><path d="M0,135.41V134.99H513V135.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(11.887749999999647,135.326)scale(0.027999999999999168)">Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome/Breast Cancer C0006142 rat GSE1872 sample 63</text></g><g class="point"><path d="M0,134.88V134.45H513V134.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(14.658968750000232,134.79399999999998)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to NOTCH Signaling Pathway/Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shSCR) GSE57677 ligand:242</text></g><g class="point"><path d="M0,134.35V133.92H513V134.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(14.253604166666893,134.26399999999998)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to WNT Signaling Pathway/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:41</text></g><g class="point"><path d="M0,133.81V133.39H513V133.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.206437500000387,133.726)scale(0.028000000000001062)">Proteins Involved in Breast Cancer Related to WNT Signaling Pathway/IRF1-19129219-H3396 breast cancer cells-human</text></g><g class="point"><path d="M0,133.28V132.85H513V133.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.816791666666806,133.194)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to ERBB2/VEGFR/Akt Signaling Pathway/breast cancer cell</text></g><g class="point"><path d="M0,132.75V132.32H513V132.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(11.64001041666685,132.664)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to ERBB2/VEGFR/Akt Signaling Pathway/IRF1-19129219-H3396 breast cancer cells-human</text></g><g class="point"><path d="M0,132.21V131.79H513V132.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.448875000000283,132.126)scale(0.028000000000001062)">Proteins Involved in Breast Cancer Related to WNT Signaling Pathway/breast cancer cell</text></g><g class="point"><path d="M0,131.68V131.25H513V131.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.848093750000173,131.594)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to WNT Signaling Pathway/Breast Cancer C0006142 human GSE1379 sample 392</text></g><g class="point"><path d="M0,131.15V130.72H513V131.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.84804166666687,131.064)scale(0.02866666666666712)">Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome/Breast Cancer DOID-1612 human GSE34925 sample 478</text></g><g class="point"><path d="M0,130.61V130.19H513V130.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.402875000000394,130.526)scale(0.028000000000001062)">Genes with Mutations Associated with Breast Cancer/Proteins Involved in Breast Cancer Related to WNT Signaling Pathway</text></g><g class="point"><path d="M0,130.08V129.65H513V130.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.526437500000199,129.994)scale(0.02866666666666712)">Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome/Breast Cancer C0006142 human GSE3744 sample 24</text></g><g class="point"><path d="M0,129.55V129.12H513V129.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.697541666666869,129.464)scale(0.02866666666666712)">Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome/breast cancer DOID-1612 human GSE9574 sample 448</text></g><g class="point"><path d="M0,129.01V128.59H513V129.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.255874999999696,128.92600000000002)scale(0.027999999999999168)">Proteins Involved in Breast Cancer Related to ESR1 Signaling Pathway/IRF1-19129219-H3396 breast cancer cells-human</text></g><g class="point"><path d="M0,128.48V128.05H513V128.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.69804166666613,128.39399999999998)scale(0.028666666666665227)">Proteins Involved in Breast Cancer Related to ESR1 Signaling Pathway/Multi-Treatment Models Breast Cancer GSE136823 4</text></g><g class="point"><path d="M0,127.95V127.52H513V127.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.89826041666684,127.864)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to ESR1 Signaling Pathway/Breast Cancer C0006142 human GSE1379 sample 392</text></g><g class="point"><path d="M0,127.41V126.99H513V127.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.538062500000043,127.326)scale(0.028000000000000115)">Proteins Involved in Breast Cancer Related to ESR1 Signaling Pathway/Breast Cancer C0006142 human GSE1378 sample 52</text></g><g class="point"><path d="M0,126.88V126.45H513V126.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(14.304218749999754,126.79399999999998)scale(0.028666666666666174)">Proteins Involved in Breast Cancer Related to ESR1 Signaling Pathway/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:41</text></g><g class="point"><path d="M0,126.35V125.92H513V126.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.945739583333145,126.26399999999998)scale(0.028666666666666174)">Proteins Involved in Breast Cancer Related to NOTCH Signaling Pathway/Breast Cancer C0006142 human GSE1378 sample 52</text></g><g class="point"><path d="M0,125.81V125.39H513V125.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(14.68556250000006,125.726)scale(0.028000000000000115)">Proteins Involved in Breast Cancer Related to NOTCH Signaling Pathway/Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shIL13RA2) GSE57677 ligand:243</text></g><g class="point"><path d="M0,125.28V124.85H513V125.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.414312500000149,125.194)scale(0.02866666666666712)">Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome/breast cancer cell</text></g><g class="point"><path d="M0,124.75V124.32H513V124.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.636177083333534,124.664)scale(0.02866666666666712)">Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome/Breast Cancer C0006142 human GSE1379 sample 392</text></g><g class="point"><path d="M0,124.21V123.79H513V124.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.402249999999631,124.12599999999999)scale(0.027999999999999168)">Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome/breast cancer DOID-1612 human GSE3744 sample 978</text></g><g class="point"><path d="M0,123.68V123.25H513V123.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.526437500000199,123.59400000000001)scale(0.02866666666666712)">Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome/Breast Cancer C0006142 human GSE2155 sample 39</text></g><g class="point"><path d="M0,123.15V122.72H513V123.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(13.476916666666881,123.06400000000001)scale(0.02866666666666712)">Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome/sporadic breast cancer DOID-8029 human GSE3744 sample 979</text></g><g class="point"><path d="M0,122.61V122.19H513V122.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.23512500000005,122.52600000000001)scale(0.028000000000000115)">Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome/Breast Cancer C0006142 human GSE1378 sample 52</text></g><g class="point"><path d="M0,122.08V121.65H513V122.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.806833333333113,121.994)scale(0.028666666666666174)">Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome/breast cancer DOID-1612 human GSE26910 sample 602</text></g><g class="point"><path d="M0,121.55V121.12H513V121.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.806833333333113,121.464)scale(0.028666666666666174)">Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome/breast cancer DOID-1612 human GSE14943 sample 504</text></g><g class="point"><path d="M0,121.01V120.59H513V121.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.34231250000005,120.92600000000002)scale(0.028000000000000115)">Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome/Breast Cancer C0006142 human GSE2429 sample 148</text></g><g class="point"><path d="M0,120.48V120.05H513V120.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.738354166666836,120.394)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to WNT Signaling Pathway/Breast Cancer C0006142 human GSE1378 sample 52</text></g><g class="point"><path d="M0,119.95V119.52H513V119.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.117145833333462,119.864)scale(0.02866666666666712)">IGF1R/AKT Signaling in Breast Cancer/Breast Cancer C0006142 human GSE1379 sample 392</text></g><g class="point"><path d="M0,119.41V118.99H513V119.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.735437500000032,119.326)scale(0.028000000000000115)">Genes with Mutations Associated with Breast Cancer/IGF1R/AKT Signaling in Breast Cancer</text></g><g class="point"><path d="M0,118.88V118.45H513V118.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.9169270833331975,118.79399999999998)scale(0.028666666666666174)">IGF1R/AKT Signaling in Breast Cancer/Multi-Treatment Models Breast Cancer GSE136823 5</text></g><g class="point"><path d="M0,118.35V117.92H513V118.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.973062499999811,118.26399999999998)scale(0.028666666666666174)">WNT Signaling in Breast Cancer/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:41</text></g><g class="point"><path d="M0,117.81V117.39H513V117.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.75668750000004,117.726)scale(0.028000000000000115)">Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome/Cancer Stem cell:Breast</text></g><g class="point"><path d="M0,117.28V116.85H513V117.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(16.501697916666927,117.194)scale(0.02866666666666712)">Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome/Stathmin and breast cancer resistance to antimicrotubule agents Homo sapiens h stathminPathway</text></g><g class="point"><path d="M0,116.75V116.32H513V116.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.168906250000114,116.664)scale(0.02866666666666712)">WNT Signaling in Breast Cancer/IRF1-19129219-H3396 breast cancer cells-human</text></g><g class="point"><path d="M0,116.21V115.79H513V116.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(4.245062499999874,116.12599999999999)scale(0.027999999999999168)">WNT Signaling in Breast Cancer/breast cancer cell</text></g><g class="point"><path d="M0,115.68V115.25H513V115.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.76607291666687,115.59400000000001)scale(0.02866666666666712)">Genes with Mutations Associated with Breast Cancer/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:41</text></g><g class="point"><path d="M0,115.15V114.72H513V115.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.567552083333453,115.06400000000001)scale(0.02866666666666712)">WNT Signaling in Breast Cancer/Breast Cancer C0006142 human GSE1379 sample 392</text></g><g class="point"><path d="M0,114.61V114.19H513V114.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.28481250000003,114.52600000000001)scale(0.028000000000000115)">WNT Signaling in Breast Cancer/Breast Cancer C0006142 human GSE1378 sample 52</text></g><g class="point"><path d="M0,114.08V113.65H513V114.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(11.547739583333135,113.994)scale(0.028666666666666174)">WNT Signaling in Breast Cancer/Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shIL13RA2) GSE57677 ligand:243</text></g><g class="point"><path d="M0,113.55V113.12H513V113.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(5.469958333333239,113.464)scale(0.028666666666666174)">IGF1R/AKT Signaling in Breast Cancer/Cancer Stem cell:Breast</text></g><g class="point"><path d="M0,113.01V112.59H513V113.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.911687500000046,112.92600000000002)scale(0.028000000000000115)">WNT Signaling in Breast Cancer/Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shSCR) GSE57677 ligand:242</text></g><g class="point"><path d="M0,112.48V112.05H513V112.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(14.133114583333558,112.394)scale(0.02866666666666712)">Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome/Proteins Involved in Breast Cancer Related to NOTCH Signaling Pathway</text></g><g class="point"><path d="M0,111.95V111.52H513V111.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(11.982666666666857,111.864)scale(0.02866666666666712)">IGF1R/AKT Signaling in Breast Cancer/Stathmin and breast cancer resistance to antimicrotubule agents Homo sapiens h stathminPathway</text></g><g class="point"><path d="M0,111.41V110.99H513V111.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.558250000000031,111.326)scale(0.028000000000000115)">WNT Signaling in Breast Cancer/breast cancer DOID-1612 human GSE14943 sample 504</text></g><g class="point"><path d="M0,110.88V110.45H513V110.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.251270833333175,110.79399999999998)scale(0.028666666666666174)">Genes with Mutations Associated with Breast Cancer/Breast Cancer C0006142 human GSE3744 sample 24</text></g><g class="point"><path d="M0,110.35V109.92H513V110.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.9169270833331975,110.26399999999998)scale(0.028666666666666174)">IGF1R/AKT Signaling in Breast Cancer/Multi-Treatment Models Breast Cancer GSE136823 3</text></g><g class="point"><path d="M0,109.81V109.39H513V109.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(4.78187500000002,109.726)scale(0.028000000000000115)">IGF1R/AKT Signaling in Breast Cancer/breast cancer cell</text></g><g class="point"><path d="M0,109.28V108.85H513V109.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.421927083333482,109.194)scale(0.02866666666666712)">Genes with Mutations Associated with Breast Cancer/breast cancer DOID-1612 human GSE9574 sample 448</text></g><g class="point"><path d="M0,108.75V108.32H513V108.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.226635416666813,108.664)scale(0.02866666666666712)">Genes with Mutations Associated with Breast Cancer/Breast Cancer C0006142 mouse GSE2528 sample 28</text></g><g class="point"><path d="M0,108.21V107.79H513V108.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.202812499999727,108.12599999999999)scale(0.027999999999999168)">Genes with Mutations Associated with Breast Cancer/breast cancer DOID-1612 human GSE3744 sample 978</text></g><g class="point"><path d="M0,107.68V107.25H513V107.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.25127083333348,107.59400000000001)scale(0.02866666666666712)">Genes with Mutations Associated with Breast Cancer/Breast Cancer C0006142 human GSE2155 sample 39</text></g><g class="point"><path d="M0,107.15V106.72H513V107.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.201302083333495,107.06400000000001)scale(0.02866666666666712)">Genes with Mutations Associated with Breast Cancer/sporadic breast cancer DOID-8029 human GSE3744 sample 979</text></g><g class="point"><path d="M0,106.61V106.19H513V106.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.036125000000037,106.52600000000001)scale(0.028000000000000115)">Genes with Mutations Associated with Breast Cancer/Breast Cancer C0006142 human GSE1378 sample 52</text></g><g class="point"><path d="M0,106.08V105.65H513V106.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.531218749999836,105.994)scale(0.028666666666666174)">Genes with Mutations Associated with Breast Cancer/breast cancer DOID-1612 human GSE26910 sample 602</text></g><g class="point"><path d="M0,105.55V105.12H513V105.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.531218749999836,105.464)scale(0.028666666666666174)">Genes with Mutations Associated with Breast Cancer/breast cancer DOID-1612 human GSE14943 sample 504</text></g><g class="point"><path d="M0,105.01V104.59H513V105.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.142875000000037,104.92600000000002)scale(0.028000000000000115)">Genes with Mutations Associated with Breast Cancer/Breast Cancer C0006142 human GSE1379 sample 392</text></g><g class="point"><path d="M0,104.48V104.05H513V104.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.895625000000141,104.394)scale(0.02866666666666712)">Genes with Mutations Associated with Breast Cancer/Breast Cancer C0006142 rat GSE1872 sample 63</text></g><g class="point"><path d="M0,103.95V103.52H513V103.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.360562500000148,103.864)scale(0.02866666666666712)">Genes with Mutations Associated with Breast Cancer/Breast Cancer C0006142 human GSE2429 sample 148</text></g><g class="point"><path d="M0,103.41V102.99H513V103.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.349812500000038,103.326)scale(0.028000000000000115)">Genes with Mutations Associated with Breast Cancer/Breast Cancer DOID-1612 human GSE34925 sample 478</text></g><g class="point"><path d="M0,102.88V102.45H513V102.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.517781249999837,102.79399999999998)scale(0.028666666666666174)">Genes with Mutations Associated with Breast Cancer/Breast cancer DOID-1612 mouse GSE24594 sample 616</text></g><g class="point"><path d="M0,102.35V101.92H513V102.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.055083333333178,102.26399999999998)scale(0.028666666666666174)">Genes with Mutations Associated with Breast Cancer/Differentially Breast Cancer Diabetes GSE150586 1</text></g><g class="point"><path d="M0,101.81V101.39H513V101.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.539437500000031,101.726)scale(0.028000000000000115)">IGF1R/AKT Signaling in Breast Cancer/IRF1-19129219-H3396 breast cancer cells-human</text></g><g class="point"><path d="M0,101.28V100.85H513V101.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.964500000000205,101.194)scale(0.02866666666666712)">Genes with Mutations Associated with Breast Cancer/Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shSCR) GSE57677 ligand:242</text></g><g class="point"><path d="M0,100.75V100.32H513V100.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.057520833333493,100.664)scale(0.02866666666666712)">Genes with Mutations Associated with Breast Cancer/estradiol human MCF-7 breast cancer cells GDS3105 ligand:38</text></g><g class="point"><path d="M0,100.21V99.79H513V100.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(13.030499999999613,100.12599999999999)scale(0.027999999999999168)">Genes with Mutations Associated with Breast Cancer/Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shIL13RA2) GSE57677 ligand:243</text></g><g class="point"><path d="M0,99.68V99.25H513V99.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.057520833333493,99.59400000000001)scale(0.02866666666666712)">Genes with Mutations Associated with Breast Cancer/estradiol human MCF-7 breast cancer cells GDS3283 ligand:42</text></g><g class="point"><path d="M0,99.15V98.72H513V99.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.250177083333464,99.06400000000001)scale(0.02866666666666712)">ERBB/VEGFR/Akt Signaling in Breast Cancer/IRF1-19129219-H3396 breast cancer cells-human</text></g><g class="point"><path d="M0,98.61V98.19H513V98.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.797562500000032,98.52600000000001)scale(0.028000000000000115)">IGF1R/AKT Signaling in Breast Cancer/Breast Cancer C0006142 mouse GSE2528 sample 28</text></g><g class="point"><path d="M0,98.08V97.65H513V98.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(11.48816666666647,97.994)scale(0.028666666666666174)">NOTCH1 Signaling in Breast Cancer/Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shSCR) GSE57677 ligand:242</text></g><g class="point"><path d="M0,97.55V97.12H513V97.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.159895833333175,97.464)scale(0.028666666666666174)">Genes with Mutations Associated with Breast Cancer/Multi-Treatment Models Breast Cancer GSE136823 1</text></g><g class="point"><path d="M0,97.01V96.59H513V97.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.24806250000003,96.92600000000002)scale(0.028000000000000115)">Genes with Mutations Associated with Breast Cancer/ESR1 Signaling in Breast Cancer</text></g><g class="point"><path d="M0,96.48V96.05H513V96.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.194833333333479,96.394)scale(0.02866666666666712)">Genes with Mutations Associated with Breast Cancer/Control Nrde2-Depleted Breast Cancer GSE119827 1</text></g><g class="point"><path d="M0,95.95V95.52H513V95.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.139145833333431,95.864)scale(0.02866666666666712)">Genes with Mutations Associated with Breast Cancer/breast cancer cell</text></g><g class="point"><path d="M0,95.41V94.99H513V95.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.732812500000032,95.326)scale(0.028000000000000115)">IGF1R/AKT Signaling in Breast Cancer/Multi-Treatment Models Breast Cancer GSE136823 6</text></g><g class="point"><path d="M0,94.88V94.45H513V94.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.9169270833331975,94.79399999999998)scale(0.028666666666666174)">IGF1R/AKT Signaling in Breast Cancer/Multi-Treatment Models Breast Cancer GSE136823 7</text></g><g class="point"><path d="M0,94.35V93.92H513V94.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.713374999999885,94.26399999999998)scale(0.028666666666666174)">Genes with Mutations Associated with Breast Cancer/Cancer Stem cell:Breast</text></g><g class="point"><path d="M0,93.81V93.39H513V93.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.918500000000053,93.726)scale(0.028000000000000115)">Genes with Mutations Associated with Breast Cancer/Stathmin and breast cancer resistance to antimicrotubule agents Homo sapiens h stathminPathway</text></g><g class="point"><path d="M0,93.28V92.85H513V93.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.117145833333462,93.194)scale(0.02866666666666712)">IGF1R/AKT Signaling in Breast Cancer/Breast Cancer C0006142 human GSE2429 sample 148</text></g><g class="point"><path d="M0,92.75V92.32H513V92.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.450843750000134,92.664)scale(0.02866666666666712)">Genes with Mutations Associated with Breast Cancer/ERBB/VEGFR/Akt Signaling in Breast Cancer</text></g><g class="point"><path d="M0,92.21V91.79H513V92.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.821624999999767,92.12599999999999)scale(0.027999999999999168)">IGF1R/AKT Signaling in Breast Cancer/Breast Cancer C0006142 human GSE2155 sample 39</text></g><g class="point"><path d="M0,91.68V91.25H513V91.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.90503125000014,91.59400000000001)scale(0.02866666666666712)">Genes with Mutations Associated with Breast Cancer/Proteins with Altered Expression in Breast Cancer</text></g><g class="point"><path d="M0,91.15V90.72H513V91.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.513895833333532,91.06400000000001)scale(0.02866666666666712)">ERBB/VEGFR/Akt Signaling in Breast Cancer/Stathmin and breast cancer resistance to antimicrotubule agents Homo sapiens h stathminPathway</text></g><g class="point"><path d="M0,90.61V90.19H513V90.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.19862500000003,90.52600000000001)scale(0.028000000000000115)">Genes with Mutations Associated with Breast Cancer/WNT Signaling in Breast Cancer</text></g><g class="point"><path d="M0,90.08V89.65H513V90.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.706499999999782,89.994)scale(0.028666666666666174)">Proteins with Altered Expression in Breast Cancer/Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shSCR) GSE57677 ligand:242</text></g><g class="point"><path d="M0,89.55V89.12H513V89.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.63762499999985,89.464)scale(0.028666666666666174)">Proteins with Altered Expression in Breast Cancer/Breast Cancer C0006142 rat GSE1872 sample 63</text></g><g class="point"><path d="M0,89.01V88.59H513V89.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.732812500000032,88.92600000000002)scale(0.028000000000000115)">IGF1R/AKT Signaling in Breast Cancer/Multi-Treatment Models Breast Cancer GSE136823 4</text></g><g class="point"><path d="M0,88.48V88.05H513V88.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.15989583333348,88.394)scale(0.02866666666666712)">Genes with Mutations Associated with Breast Cancer/Multi-Treatment Models Breast Cancer GSE136823 2</text></g><g class="point"><path d="M0,87.95V87.52H513V87.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(2.809333333333378,87.864)scale(0.02866666666666712)">Breast Cancer/breast cancer cell</text></g><g class="point"><path d="M0,87.41V86.99H513V87.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(4.553937500000019,87.326)scale(0.028000000000000115)">NOTCH1 Signaling in Breast Cancer/breast cancer cell</text></g><g class="point"><path d="M0,86.88V86.45H513V86.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.097333333333125,86.79399999999998)scale(0.028666666666666174)">IGF1R/AKT Signaling in Breast Cancer/Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shIL13RA2) GSE57677 ligand:243</text></g><g class="point"><path d="M0,86.35V85.92H513V86.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(11.289739583333139,86.26399999999998)scale(0.028666666666666174)">NOTCH1 Signaling in Breast Cancer/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:41</text></g><g class="point"><path d="M0,85.81V85.39H513V85.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.593687500000031,85.726)scale(0.028000000000000115)">NOTCH1 Signaling in Breast Cancer/Breast Cancer C0006142 human GSE1378 sample 52</text></g><g class="point"><path d="M0,85.28V84.85H513V85.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.883781250000125,85.194)scale(0.02866666666666712)">NOTCH1 Signaling in Breast Cancer/Breast Cancer C0006142 human GSE1379 sample 392</text></g><g class="point"><path d="M0,84.75V84.32H513V84.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(11.721531250000186,84.664)scale(0.02866666666666712)">IGF1R/AKT Signaling in Breast Cancer/Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shSCR) GSE57677 ligand:242</text></g><g class="point"><path d="M0,84.21V83.79H513V84.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.501499999999748,84.12599999999999)scale(0.027999999999999168)">Proteins with Altered Expression in Breast Cancer/IRF1-19129219-H3396 breast cancer cells-human</text></g><g class="point"><path d="M0,83.68V83.25H513V83.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.936833333333475,83.59400000000001)scale(0.02866666666666712)">Proteins with Altered Expression in Breast Cancer/Control Nrde2-Depleted Breast Cancer GSE119827 1</text></g><g class="point"><path d="M0,83.15V82.72H513V83.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.485583333333452,83.06400000000001)scale(0.02866666666666712)">NOTCH1 Signaling in Breast Cancer/IRF1-19129219-H3396 breast cancer cells-human</text></g><g class="point"><path d="M0,82.61V82.19H513V82.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(11.588062500000047,82.52600000000001)scale(0.028000000000000115)">NOTCH1 Signaling in Breast Cancer/Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shIL13RA2) GSE57677 ligand:243</text></g><g class="point"><path d="M0,82.08V81.65H513V82.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.102562499999843,81.994)scale(0.028666666666666174)">Proteins with Altered Expression in Breast Cancer/Breast Cancer C0006142 human GSE1379 sample 392</text></g><g class="point"><path d="M0,81.55V81.12H513V81.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.27321874999984,81.464)scale(0.028666666666666174)">Proteins with Altered Expression in Breast Cancer/breast cancer DOID-1612 human GSE14943 sample 504</text></g><g class="point"><path d="M0,81.01V80.59H513V81.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.21718750000005,80.92600000000002)scale(0.028000000000000115)">Proteins with Altered Expression in Breast Cancer/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:41</text></g><g class="point"><path d="M0,80.48V80.05H513V80.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(14.120572916666891,80.394)scale(0.02866666666666712)">Stathmin and breast cancer resistance to antimicrotubule agents Homo sapiens h stathminPathway/estradiol human MCF-7 breast cancer cells GDS3105 ligand:38</text></g><g class="point"><path d="M0,79.95V79.52H513V79.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.382708333333499,79.864)scale(0.02866666666666712)">Proteins Involved in Breast Cancer Related to WNT Signaling Pathway/Breast Cancer C0006142 rat GSE1872 sample 63</text></g><g class="point"><path d="M0,79.41V78.99H513V79.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(15.668625000000064,79.326)scale(0.028000000000000115)">Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:41</text></g><g class="point"><path d="M0,78.88V78.45H513V78.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(11.165666666666475,78.79399999999998)scale(0.028666666666666174)">Breast cancer pathway WP4262/Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shSCR) GSE57677 ligand:242</text></g><g class="point"><path d="M0,78.35V77.92H513V78.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(11.541916666666468,78.26399999999998)scale(0.028666666666666174)">Breast cancer pathway WP4262/Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shIL13RA2) GSE57677 ligand:243</text></g><g class="point"><path d="M0,77.81V77.39H513V77.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(13.265000000000054,77.726)scale(0.028000000000000115)">Stathmin and breast cancer resistance to antimicrotubule agents Homo sapiens h stathminPathway/Breast cancer DOID-1612 mouse GSE24594 sample 616</text></g><g class="point"><path d="M0,77.28V76.85H513V77.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(13.423614583333546,77.194)scale(0.02866666666666712)">Stathmin and breast cancer resistance to antimicrotubule agents Homo sapiens h stathminPathway/Breast Cancer C0006142 human GSE2429 sample 148</text></g><g class="point"><path d="M0,76.75V76.32H513V76.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.7769791666667745,76.664)scale(0.02866666666666712)">Cancer Stem cell:Breast/Breast Cancer C0006142 mouse GSE2528 sample 28</text></g><g class="point"><path d="M0,76.21V75.79H513V76.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(13.278124999999605,76.12599999999999)scale(0.027999999999999168)">Stathmin and breast cancer resistance to antimicrotubule agents Homo sapiens h stathminPathway/breast cancer DOID-1612 human GSE14943 sample 504</text></g><g class="point"><path d="M0,75.68V75.25H513V75.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.412218750000196,75.59400000000001)scale(0.02866666666666712)">ESR1/ERBB Positive Luminal Breast Cancer/Stathmin and breast cancer resistance to antimicrotubule agents Homo sapiens h stathminPathway</text></g><g class="point"><path d="M0,75.15V74.72H513V75.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(13.59427083333355,75.06400000000001)scale(0.02866666666666712)">Stathmin and breast cancer resistance to antimicrotubule agents Homo sapiens h stathminPathway/breast cancer DOID-1612 human GSE26910 sample 602</text></g><g class="point"><path d="M0,74.61V74.19H513V74.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.961125000000045,74.52600000000001)scale(0.028000000000000115)">ESR1 Signaling in Breast Cancer/Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shSCR) GSE57677 ligand:242</text></g><g class="point"><path d="M0,74.08V73.65H513V74.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(14.264354166666422,73.994)scale(0.028666666666666174)">Stathmin and breast cancer resistance to antimicrotubule agents Homo sapiens h stathminPathway/sporadic breast cancer DOID-8029 human GSE3744 sample 979</text></g><g class="point"><path d="M0,73.55V73.12H513V73.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(11.483687499999803,73.464)scale(0.028666666666666174)">ESR1 Signaling in Breast Cancer/Stathmin and breast cancer resistance to antimicrotubule agents Homo sapiens h stathminPathway</text></g><g class="point"><path d="M0,73.01V72.59H513V73.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.251687500000035,72.92600000000002)scale(0.028000000000000115)">ERBB/VEGFR/Akt Signaling in Breast Cancer/Multi-Treatment Models Breast Cancer GSE136823 7</text></g><g class="point"><path d="M0,72.48V72.05H513V72.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.961864583333508,72.394)scale(0.02866666666666712)">NOTCH1 Signaling in Breast Cancer/Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome</text></g><g class="point"><path d="M0,71.95V71.52H513V71.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.686250000000122,71.864)scale(0.02866666666666712)">NOTCH1 Signaling in Breast Cancer/Genes with Mutations Associated with Breast Cancer</text></g><g class="point"><path d="M0,71.41V70.99H513V71.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.347937500000034,71.326)scale(0.028000000000000115)">ESR1/ERBB Positive Luminal Breast Cancer/Breast Cancer C0006142 human GSE2429 sample 148</text></g><g class="point"><path d="M0,70.88V70.45H513V70.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(13.11813541666644,70.79399999999998)scale(0.028666666666666174)">Stathmin and breast cancer resistance to antimicrotubule agents Homo sapiens h stathminPathway/Differentially Breast Cancer Diabetes GSE150586 1</text></g><g class="point"><path d="M0,70.35V69.92H513V70.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(13.22294791666644,70.26399999999998)scale(0.028666666666666174)">Stathmin and breast cancer resistance to antimicrotubule agents Homo sapiens h stathminPathway/Multi-Treatment Models Breast Cancer GSE136823 1</text></g><g class="point"><path d="M0,69.81V69.39H513V69.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.96493750000004,69.726)scale(0.028000000000000115)">Stathmin and breast cancer resistance to antimicrotubule agents Homo sapiens h stathminPathway/breast cancer cell</text></g><g class="point"><path d="M0,69.28V68.85H513V69.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(13.515437500000214,69.194)scale(0.02866666666666712)">Stathmin and breast cancer resistance to antimicrotubule agents/Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome</text></g><g class="point"><path d="M0,68.75V68.32H513V68.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.23982291666683,68.664)scale(0.02866666666666712)">Stathmin and breast cancer resistance to antimicrotubule agents/Genes with Mutations Associated with Breast Cancer</text></g><g class="point"><path d="M0,68.21V67.79H513V68.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.7195624999998005,68.12599999999999)scale(0.027999999999999168)">Stathmin and breast cancer resistance to antimicrotubule agents/Breast cancer</text></g><g class="point"><path d="M0,67.68V67.25H513V67.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.4405416666668,67.59400000000001)scale(0.02866666666666712)">Stathmin and breast cancer resistance to antimicrotubule agents/Breast cancer pathway WP4262</text></g><g class="point"><path d="M0,67.15V66.72H513V67.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.399979166666816,67.06400000000001)scale(0.02866666666666712)">Stathmin and breast cancer resistance to antimicrotubule agents/Integrated breast cancer pathway WP1984</text></g><g class="point"><path d="M0,66.61V66.19H513V66.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(11.089312500000046,66.52600000000001)scale(0.028000000000000115)">Integrated breast cancer pathway/Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shSCR) GSE57677 ligand:242</text></g><g class="point"><path d="M0,66.08V65.65H513V66.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.792156249999849,65.994)scale(0.028666666666666174)">Integrated breast cancer pathway WP1984/Integrated Breast Cancer Pathway Homo sapiens WP1984</text></g><g class="point"><path d="M0,65.55V65.12H513V65.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.17094791666656,65.464)scale(0.028666666666666174)">breast cancer cell/Control Nrde2-Depleted Breast Cancer GSE119827 1</text></g><g class="point"><path d="M0,65.01V64.59H513V65.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.296062500000026,64.92600000000002)scale(0.028000000000000115)">Cancer Stem cell:Breast/Breast Cancer C0006142 rat GSE1872 sample 63</text></g><g class="point"><path d="M0,64.48V64.05H513V64.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(13.222947916666877,64.394)scale(0.02866666666666712)">Stathmin and breast cancer resistance to antimicrotubule agents Homo sapiens h stathminPathway/Multi-Treatment Models Breast Cancer GSE136823 2</text></g><g class="point"><path d="M0,63.95V63.52H513V63.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.412770833333328,63.864)scale(0.02866666666666665)">ESR1/ERBB Positive Luminal Breast Cancer/Breast Cancer C0006142 mouse GSE2528 sample 28</text></g><g class="point"><path d="M0,63.41V62.99H513V63.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.525812499999864,63.326)scale(0.02799999999999964)">Stathmin and breast cancer resistance to antimicrotubule agents Homo sapiens h stathminPathway/Cancer Stem cell:Breast</text></g><g class="point"><path d="M0,62.88V62.45H513V62.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.420281249999993,62.794000000000004)scale(0.02866666666666665)">Stathmin and breast cancer resistance to antimicrotubule agents Homo sapiens h stathminPathway/Integrated Breast Cancer Pathway WP1984</text></g><g class="point"><path d="M0,62.35V61.92H513V62.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(13.69460416666666,62.264)scale(0.02866666666666665)">Stathmin and breast cancer resistance to antimicrotubule agents Homo sapiens h stathminPathway/Integrated Breast Cancer Pathway Homo sapiens WP1984</text></g><g class="point"><path d="M0,61.81V61.39H513V61.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.722062500000053,61.726)scale(0.028000000000000115)">Stathmin and breast cancer resistance to antimicrotubule agents Homo sapiens h stathminPathway/IRF1-19129219-H3396 breast cancer cells-human</text></g><g class="point"><path d="M0,61.28V60.85H513V61.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.604677083333328,61.193999999999996)scale(0.02866666666666665)">Breast cancer/Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shSCR) GSE57677 ligand:242</text></g><g class="point"><path d="M0,60.75V60.32H513V60.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.98047916666666,60.663999999999994)scale(0.02866666666666665)">Breast cancer/Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shIL13RA2) GSE57677 ligand:243</text></g><g class="point"><path d="M0,60.21V59.79H513V60.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.447250000000034,60.126)scale(0.028000000000000115)">ERBB/VEGFR/Akt Signaling in Breast Cancer/Breast Cancer C0006142 human GSE2429 sample 148</text></g><g class="point"><path d="M0,59.68V59.25H513V59.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.514447916666661,59.594)scale(0.02866666666666665)">ERBB/VEGFR/Akt Signaling in Breast Cancer/Breast Cancer C0006142 mouse GSE2528 sample 28</text></g><g class="point"><path d="M0,59.15V58.72H513V59.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.801614583333329,59.064)scale(0.02866666666666665)">Cancer Stem cell:Breast/Breast Cancer C0006142 human GSE2155 sample 39</text></g><g class="point"><path d="M0,58.61V58.19H513V58.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.554625000000027,58.525999999999996)scale(0.028000000000000115)">Cancer Stem cell:Breast/Multi-Treatment Models Breast Cancer GSE136823 6</text></g><g class="point"><path d="M0,58.08V57.65H513V58.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.710687499999996,57.99399999999999)scale(0.02866666666666665)">Cancer Stem cell:Breast/Multi-Treatment Models Breast Cancer GSE136823 5</text></g><g class="point"><path d="M0,57.55V57.12H513V57.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.710687499999996,57.46399999999999)scale(0.02866666666666665)">Cancer Stem cell:Breast/Multi-Treatment Models Breast Cancer GSE136823 4</text></g><g class="point"><path d="M0,57.01V56.59H513V57.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.554624999999915,56.925999999999995)scale(0.02799999999999964)">Cancer Stem cell:Breast/Multi-Treatment Models Breast Cancer GSE136823 3</text></g><g class="point"><path d="M0,56.48V56.05H513V56.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.910906249999996,56.394)scale(0.02866666666666665)">Cancer Stem cell:Breast/Breast Cancer C0006142 human GSE2429 sample 148</text></g><g class="point"><path d="M0,55.95V55.52H513V55.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.710687499999996,55.864)scale(0.02866666666666665)">Cancer Stem cell:Breast/Multi-Treatment Models Breast Cancer GSE136823 1</text></g><g class="point"><path d="M0,55.41V54.99H513V55.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.588312499999915,55.326)scale(0.02799999999999964)">Cancer Stem cell:Breast/Control Nrde2-Depleted Breast Cancer GSE119827 1</text></g><g class="point"><path d="M0,54.88V54.45H513V54.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.123218749999996,54.794000000000004)scale(0.02866666666666665)">Cancer Stem cell:Breast/Breast Cancer DOID-1612 human GSE34925 sample 478</text></g><g class="point"><path d="M0,54.35V53.92H513V54.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.51270833333333,54.264)scale(0.02866666666666665)">Cancer Stem cell:Breast/IRF1-19129219-H3396 breast cancer cells-human</text></g><g class="point"><path d="M0,53.81V53.39H513V53.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(13.004687500000053,53.726)scale(0.028000000000000115)">Stathmin and breast cancer resistance to antimicrotubule agents Homo sapiens h stathminPathway/Breast Cancer C0006142 human GSE3744 sample 24</text></g><g class="point"><path d="M0,53.28V52.85H513V53.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(17.40380208333332,53.193999999999996)scale(0.02866666666666665)">Stathmin and breast cancer resistance to antimicrotubule agents Homo sapiens h stathminPathway/Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shIL13RA2) GSE57677 ligand:243</text></g><g class="point"><path d="M0,52.75V52.32H513V52.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(14.120572916666658,52.663999999999994)scale(0.02866666666666665)">Stathmin and breast cancer resistance to antimicrotubule agents Homo sapiens h stathminPathway/estradiol human MCF-7 breast cancer cells GDS3283 ligand:42</text></g><g class="point"><path d="M0,52.21V51.79H513V52.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(13.792187500000058,52.126)scale(0.028000000000000115)">Stathmin and breast cancer resistance to antimicrotubule agents Homo sapiens h stathminPathway/estradiol human MCF-7 breast cancer cells GDS3283 ligand:43</text></g><g class="point"><path d="M0,51.68V51.25H513V51.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(13.484979166666658,51.594)scale(0.02866666666666665)">Stathmin and breast cancer resistance to antimicrotubule agents Homo sapiens h stathminPathway/breast cancer DOID-1612 human GSE3744 sample 978</text></g><g class="point"><path d="M0,51.15V50.72H513V51.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.082010416666662,51.064)scale(0.02866666666666665)">Cancer Stem cell:Breast/breast cancer DOID-1612 human GSE14943 sample 504</text></g><g class="point"><path d="M0,50.61V50.19H513V50.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.438375000000031,50.525999999999996)scale(0.028000000000000115)">Integrated breast cancer pathway/Breast Cancer C0006142 mouse GSE2528 sample 28</text></g><g class="point"><path d="M0,50.08V49.65H513V50.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.710687499999996,49.99399999999999)scale(0.02866666666666665)">Cancer Stem cell:Breast/Multi-Treatment Models Breast Cancer GSE136823 7</text></g><g class="point"><path d="M0,49.55V49.12H513V49.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(4.0039270833333305,49.46399999999999)scale(0.02866666666666665)">Breast cancer pathway WP4262/Breast cancer</text></g><g class="point"><path d="M0,49.01V48.59H513V49.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(4.855374999999937,48.925999999999995)scale(0.02799999999999964)">ESR1 Signaling in Breast Cancer/Cancer Stem cell:Breast</text></g><g class="point"><path d="M0,48.48V48.05H513V48.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(11.59835416666666,48.394)scale(0.02866666666666665)">ESR1 Signaling in Breast Cancer/Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shIL13RA2) GSE57677 ligand:243</text></g><g class="point"><path d="M0,47.95V47.52H513V47.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.219520833333329,47.864)scale(0.02866666666666665)">ESR1 Signaling in Breast Cancer/IRF1-19129219-H3396 breast cancer cells-human</text></g><g class="point"><path d="M0,47.41V46.99H513V47.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.244999999999907,47.326)scale(0.02799999999999964)">ESR1 Signaling in Breast Cancer/Multi-Treatment Models Breast Cancer GSE136823 4</text></g><g class="point"><path d="M0,46.88V46.45H513V46.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.618166666666662,46.794000000000004)scale(0.02866666666666665)">ESR1 Signaling in Breast Cancer/Breast Cancer C0006142 human GSE2429 sample 148</text></g><g class="point"><path d="M0,46.35V45.92H513V46.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.865812499999993,46.264)scale(0.02866666666666665)">Breast cancer/Stathmin and breast cancer resistance to antimicrotubule agents Homo sapiens h stathminPathway</text></g><g class="point"><path d="M0,45.81V45.39H513V45.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.607687500000031,45.726)scale(0.028000000000000115)">ESR1 Signaling in Breast Cancer/breast cancer DOID-1612 human GSE14943 sample 504</text></g><g class="point"><path d="M0,45.28V44.85H513V45.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.484239583333329,45.193999999999996)scale(0.02866666666666665)">ESR1 Signaling in Breast Cancer/Breast Cancer C0006142 mouse GSE2528 sample 28</text></g><g class="point"><path d="M0,44.75V44.32H513V44.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.152781249999996,44.663999999999994)scale(0.02866666666666665)">ESR1 Signaling in Breast Cancer/Breast Cancer C0006142 rat GSE1872 sample 63</text></g><g class="point"><path d="M0,44.21V43.79H513V44.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(13.004687500000053,44.126)scale(0.028000000000000115)">Stathmin and breast cancer resistance to antimicrotubule agents Homo sapiens h stathminPathway/Breast Cancer C0006142 human GSE1378 sample 52</text></g><g class="point"><path d="M0,43.68V43.25H513V43.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(13.423614583333325,43.594)scale(0.02866666666666665)">Stathmin and breast cancer resistance to antimicrotubule agents Homo sapiens h stathminPathway/Breast Cancer C0006142 human GSE1379 sample 392</text></g><g class="point"><path d="M0,43.15V42.72H513V43.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.710687499999996,43.064)scale(0.02866666666666665)">Cancer Stem cell:Breast/Multi-Treatment Models Breast Cancer GSE136823 2</text></g><g class="point"><path d="M0,42.61V42.19H513V42.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(3.603687500000015,42.525999999999996)scale(0.028000000000000115)">Cancer Stem cell:Breast/breast cancer cell</text></g><g class="point"><path d="M0,42.08V41.65H513V42.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.387239583333328,41.99399999999999)scale(0.02866666666666665)">Integrated breast cancer pathway WP1984/Breast Cancer C0006142 mouse GSE2528 sample 28</text></g><g class="point"><path d="M0,41.55V41.12H513V41.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.12510416666666,41.46399999999999)scale(0.02866666666666665)">Integrated breast cancer pathway WP1984/Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shSCR) GSE57677 ligand:242</text></g><g class="point"><path d="M0,41.01V40.59H513V41.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.451812499999917,40.925999999999995)scale(0.02799999999999964)">Cancer Stem cell:Breast/Differentially Breast Cancer Diabetes GSE150586 1</text></g><g class="point"><path d="M0,40.48V40.05H513V40.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(14.828281249999991,40.394)scale(0.02866666666666665)">Proteins Involved in Breast Cancer Related to WNT Signaling Pathway/Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shIL13RA2) GSE57677 ligand:243</text></g><g class="point"><path d="M0,39.95V39.52H513V39.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.929864583333327,39.864)scale(0.02866666666666665)">Stathmin and breast cancer resistance to antimicrotubule agents/Hereditary Breast and Ovarian Cancer Syndrome</text></g><g class="point"><path d="M0,39.41V38.99H513V39.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.749312499999913,39.326)scale(0.02799999999999964)">Stathmin and breast cancer resistance to antimicrotubule agents/Breast Cancer</text></g><g class="point"><path d="M0,38.88V38.45H513V38.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.157208333333328,38.794000000000004)scale(0.02866666666666665)">Multi-Treatment Models Breast Cancer GSE136823 4/Multi-Treatment Models Breast Cancer GSE136823 6</text></g><g class="point"><path d="M0,38.35V37.92H513V38.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.157208333333328,38.264)scale(0.02866666666666665)">Multi-Treatment Models Breast Cancer GSE136823 4/Multi-Treatment Models Breast Cancer GSE136823 7</text></g><g class="point"><path d="M0,37.81V37.39H513V37.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.944250000000038,37.726)scale(0.028000000000000115)">Multi-Treatment Models Breast Cancer GSE136823 5/Multi-Treatment Models Breast Cancer GSE136823 6</text></g><g class="point"><path d="M0,37.28V36.85H513V37.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.236687499999993,37.193999999999996)scale(0.02866666666666665)">Stathmin and breast cancer resistance to antimicrotubule agents/Multi-Treatment Models Breast Cancer GSE136823 2</text></g><g class="point"><path d="M0,36.75V36.32H513V36.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.236687499999993,36.663999999999994)scale(0.02866666666666665)">Stathmin and breast cancer resistance to antimicrotubule agents/Multi-Treatment Models Breast Cancer GSE136823 1</text></g><g class="point"><path d="M0,36.21V35.79H513V36.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.048125000000029,36.126)scale(0.028000000000000115)">Stathmin and breast cancer resistance to antimicrotubule agents/breast cancer cell</text></g><g class="point"><path d="M0,35.68V35.25H513V35.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.131874999999994,35.594)scale(0.02866666666666665)">Stathmin and breast cancer resistance to antimicrotubule agents/Differentially Breast Cancer Diabetes GSE150586 1</text></g><g class="point"><path d="M0,35.15V34.72H513V35.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.038708333333327,35.064)scale(0.02866666666666665)">Stathmin and breast cancer resistance to antimicrotubule agents/IRF1-19129219-H3396 breast cancer cells-human</text></g><g class="point"><path d="M0,34.61V34.19H513V34.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(14.082250000000057,34.525999999999996)scale(0.028000000000000115)">Stathmin and breast cancer resistance to antimicrotubule agents/Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shIL13RA2) GSE57677 ligand:243</text></g><g class="point"><path d="M0,34.08V33.65H513V34.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.198614583333327,33.99399999999999)scale(0.02866666666666665)">Multi-Treatment Models Breast Cancer GSE136823 3/sporadic breast cancer DOID-8029 human GSE3744 sample 979</text></g><g class="point"><path d="M0,33.55V33.12H513V33.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.420833333333329,33.46399999999999)scale(0.02866666666666665)">Integrated Breast Cancer Pathway WP1984/Breast Cancer C0006142 mouse GSE2528 sample 28</text></g><g class="point"><path d="M0,33.01V32.59H513V33.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.3425624999999055,32.925999999999995)scale(0.02799999999999964)">Integrated breast cancer pathway WP1984/Integrated Breast Cancer Pathway WP1984</text></g><g class="point"><path d="M0,32.48V32.05H513V32.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.386687499999992,32.394)scale(0.02866666666666665)">Integrated breast cancer pathway WP1984/Stathmin and breast cancer resistance to antimicrotubule agents Homo sapiens h stathminPathway</text></g><g class="point"><path d="M0,31.95V31.52H513V31.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.316864583333327,31.864)scale(0.02866666666666665)">Cancer Stem cell:Breast/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:40</text></g><g class="point"><path d="M0,31.41V30.99H513V31.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.685687500000036,31.326)scale(0.028000000000000115)">Multi-Treatment Models Breast Cancer GSE136823 3/Breast Cancer C0006142 rat GSE1872 sample 63</text></g><g class="point"><path d="M0,30.88V30.45H513V30.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.43735416666666,30.794)scale(0.02866666666666665)">Stathmin and breast cancer resistance to antimicrotubule agents/Breast Cancer C0006142 human GSE1379 sample 392</text></g><g class="point"><path d="M0,30.35V29.92H513V30.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.60801041666666,30.264000000000003)scale(0.02866666666666665)">Stathmin and breast cancer resistance to antimicrotubule agents/breast cancer DOID-1612 human GSE14943 sample 504</text></g><g class="point"><path d="M0,29.81V29.39H513V29.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.361312499999954,29.726)scale(0.027999999999999876)">Stathmin and breast cancer resistance to antimicrotubule agents/breast cancer DOID-1612 human GSE26910 sample 602</text></g><g class="point"><path d="M0,29.28V28.85H513V29.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(14.452031249999992,29.194000000000003)scale(0.02866666666666665)">Proteins Involved in Breast Cancer Related to WNT Signaling Pathway/Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shSCR) GSE57677 ligand:242</text></g><g class="point"><path d="M0,28.75V28.32H513V28.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(16.240114583333323,28.664)scale(0.02866666666666665)">Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome/Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shSCR) GSE57677 ligand:242</text></g><g class="point"><path d="M0,28.21V27.79H513V28.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(15.668625000000064,28.126)scale(0.028000000000000115)">Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:39</text></g><g class="point"><path d="M0,27.68V27.25H513V27.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(13.333135416666659,27.594)scale(0.02866666666666665)">Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome/estradiol human MCF-7 breast cancer cells GDS3105 ligand:38</text></g><g class="point"><path d="M0,27.15V26.72H513V27.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(16.04168749999999,27.064)scale(0.02866666666666665)">Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:40</text></g><g class="point"><path d="M0,26.61V26.19H513V26.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(16.229937499999927,26.525999999999996)scale(0.027999999999999876)">Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome/Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shIL13RA2) GSE57677 ligand:243</text></g><g class="point"><path d="M0,26.08V25.65H513V26.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(13.333135416666659,25.994)scale(0.02866666666666665)">Genes with Mutations Associated with Hereditary Breast and/or Ovarian Cancer Syndrome/estradiol human MCF-7 breast cancer cells GDS3283 ligand:42</text></g><g class="point"><path d="M0,25.55V25.12H513V25.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(5.42695833333333,25.464000000000002)scale(0.02866666666666665)">ERBB/VEGFR/Akt Signaling in Breast Cancer/breast cancer cell</text></g><g class="point"><path d="M0,25.01V24.59H513V25.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.778500000000053,24.926000000000002)scale(0.028000000000000115)">Proteins with Altered Expression in Breast Cancer/Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shIL13RA2) GSE57677 ligand:243</text></g><g class="point"><path d="M0,24.48V24.05H513V24.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.448156249999995,24.394000000000002)scale(0.02866666666666665)">ERBB/VEGFR/Akt Signaling in Breast Cancer/Multi-Treatment Models Breast Cancer GSE136823 5</text></g><g class="point"><path d="M0,23.95V23.52H513V23.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.43357291666666,23.864)scale(0.02866666666666665)">Stathmin and breast cancer resistance to antimicrotubule agents/Integrated Breast Cancer Pathway WP1984</text></g><g class="point"><path d="M0,23.41V22.99H513V23.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.087875000000041,23.326)scale(0.028000000000000115)">Stathmin and breast cancer resistance to antimicrotubule agents/Breast Cancer C0006142 human GSE3744 sample 24</text></g><g class="point"><path d="M0,22.88V22.45H513V22.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.498718749999993,22.794)scale(0.02866666666666665)">Stathmin and breast cancer resistance to antimicrotubule agents/breast cancer DOID-1612 human GSE3744 sample 978</text></g><g class="point"><path d="M0,22.35V21.92H513V22.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(11.278093749999993,22.264000000000003)scale(0.02866666666666665)">Stathmin and breast cancer resistance to antimicrotubule agents/sporadic breast cancer DOID-8029 human GSE3744 sample 979</text></g><g class="point"><path d="M0,21.81V21.39H513V21.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.087874999999956,21.726)scale(0.027999999999999876)">Stathmin and breast cancer resistance to antimicrotubule agents/Breast Cancer C0006142 human GSE1378 sample 52</text></g><g class="point"><path d="M0,21.28V20.85H513V21.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.6078645833333285,21.194000000000003)scale(0.02866666666666665)">Cancer Stem cell:Breast/estradiol human MCF-7 breast cancer cells GDS3105 ligand:38</text></g><g class="point"><path d="M0,20.75V20.32H513V20.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.316864583333327,20.664)scale(0.02866666666666665)">Cancer Stem cell:Breast/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:39</text></g><g class="point"><path d="M0,20.21V19.79H513V20.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.620500000000035,20.126)scale(0.028000000000000115)">Integrated Breast Cancer Pathway WP1984/Integrated Breast Cancer Pathway Homo sapiens WP1984</text></g><g class="point"><path d="M0,19.68V19.25H513V19.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.158697916666659,19.594)scale(0.02866666666666665)">Integrated Breast Cancer Pathway WP1984/Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shSCR) GSE57677 ligand:242</text></g><g class="point"><path d="M0,19.15V18.72H513V19.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.892489583333328,19.064)scale(0.02866666666666665)">Multi-Treatment Models Breast Cancer GSE136823 6/Breast Cancer C0006142 rat GSE1872 sample 63</text></g><g class="point"><path d="M0,18.61V18.19H513V18.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.347187499999958,18.525999999999996)scale(0.027999999999999876)">Multi-Treatment Models Breast Cancer GSE136823 7/Breast Cancer DOID-1612 human GSE34925 sample 478</text></g><g class="point"><path d="M0,18.08V17.65H513V18.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.961812499999992,17.994)scale(0.02866666666666665)">Multi-Treatment Models Breast Cancer GSE136823 7/Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shSCR) GSE57677 ligand:242</text></g><g class="point"><path d="M0,17.55V17.12H513V17.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.46019791666666,17.464000000000002)scale(0.02866666666666665)">sporadic breast cancer DOID-8029 human GSE3744 sample 979/breast cancer DOID-1612 human GSE3744 sample 978</text></g><g class="point"><path d="M0,17.01V16.59H513V17.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.050250000000041,16.926000000000002)scale(0.028000000000000115)">sporadic breast cancer DOID-8029 human GSE3744 sample 979/Breast Cancer C0006142 human GSE3744 sample 24</text></g><g class="point"><path d="M0,16.48V16.05H513V16.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.510166666666661,16.394000000000002)scale(0.02866666666666665)">breast cancer DOID-1612 human GSE3744 sample 978/Breast Cancer C0006142 human GSE3744 sample 24</text></g><g class="point"><path d="M0,15.95V15.52H513V15.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(16.36956249999999,15.863999999999999)scale(0.02866666666666665)">estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:41/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:40</text></g><g class="point"><path d="M0,15.41V14.99H513V15.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.961437499999997,15.325999999999999)scale(0.027999999999999994)">Multi-Treatment Models Breast Cancer GSE136823 5/sporadic breast cancer DOID-8029 human GSE3744 sample 979</text></g><g class="point"><path d="M0,14.88V14.45H513V14.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.357427083333366,14.794)scale(0.028666666666666767)">Multi-Treatment Models Breast Cancer GSE136823 5/Breast Cancer C0006142 human GSE1379 sample 392</text></g><g class="point"><path d="M0,14.35V13.92H513V14.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.569739583333327,14.264)scale(0.02866666666666665)">Multi-Treatment Models Breast Cancer GSE136823 5/Breast Cancer DOID-1612 human GSE34925 sample 478</text></g><g class="point"><path d="M0,13.81V13.39H513V13.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(11.503624999999998,13.726)scale(0.027999999999999994)">Stathmin and breast cancer resistance to antimicrotubule agents/Proteins Involved in Breast Cancer Related to ESR1 Signaling Pathway</text></g><g class="point"><path d="M0,13.28V12.85H513V13.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.425958333333327,13.193999999999999)scale(0.02866666666666665)">Stathmin and breast cancer resistance to antimicrotubule agents/ESR1/ERBB Positive Luminal Breast Cancer</text></g><g class="point"><path d="M0,12.75V12.32H513V12.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.497427083333328,12.664)scale(0.02866666666666665)">Stathmin and breast cancer resistance to antimicrotubule agents/ESR1 Signaling in Breast Cancer</text></g><g class="point"><path d="M0,12.21V11.79H513V12.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.306062500000039,12.126000000000001)scale(0.028000000000000115)">Stathmin and breast cancer resistance to antimicrotubule agents/ERBB/VEGFR/Akt Signaling in Breast Cancer</text></g><g class="point"><path d="M0,11.68V11.25H513V11.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.996406249999994,11.594)scale(0.02866666666666665)">Stathmin and breast cancer resistance to antimicrotubule agents/IGF1R/AKT Signaling in Breast Cancer</text></g><g class="point"><path d="M0,11.15V10.72H513V11.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.198614583333327,11.064)scale(0.02866666666666665)">Multi-Treatment Models Breast Cancer GSE136823 6/sporadic breast cancer DOID-8029 human GSE3744 sample 979</text></g><g class="point"><path d="M0,10.61V10.19H513V10.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(11.937187499999997,10.525999999999998)scale(0.027999999999999994)">Stathmin and breast cancer resistance to antimicrotubule agents/Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway</text></g><g class="point"><path d="M0,10.08V9.65H513V10.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.419239583333328,9.994)scale(0.02866666666666665)">Multi-Treatment Models Breast Cancer GSE136823 6/breast cancer DOID-1612 human GSE9574 sample 448</text></g><g class="point"><path d="M0,9.55V9.12H513V9.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(11.614927083333374,9.464000000000002)scale(0.028666666666666767)">Integrated breast cancer pathway/Stathmin and breast cancer resistance to antimicrotubule agents Homo sapiens h stathminPathway</text></g><g class="point"><path d="M0,9.01V8.59H513V9.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.841874999999998,8.926)scale(0.027999999999999994)">Multi-Treatment Models Breast Cancer GSE136823 3/Differentially Breast Cancer Diabetes GSE150586 1</text></g><g class="point"><path d="M0,8.48V8.05H513V8.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.695156249999995,8.394)scale(0.02866666666666665)">Integrated Breast Cancer Pathway Homo sapiens WP1984/Breast Cancer C0006142 mouse GSE2528 sample 28</text></g><g class="point"><path d="M0,7.95V7.52H513V7.95Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.15944791666668,7.864)scale(0.02866666666666671)">IRF1-19129219-H3396 breast cancer cells-human/Breast Cancer C0006142 human GSE1379 sample 392</text></g><g class="point"><path d="M0,7.41V6.99H513V7.41Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.251687499999997,7.3260000000000005)scale(0.027999999999999994)">ERBB/VEGFR/Akt Signaling in Breast Cancer/Multi-Treatment Models Breast Cancer GSE136823 6</text></g><g class="point"><path d="M0,6.88V6.45H513V6.88Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.996302083333326,6.794)scale(0.02866666666666665)">Control Nrde2-Depleted Breast Cancer GSE119827 1/Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shSCR) GSE57677 ligand:242</text></g><g class="point"><path d="M0,6.35V5.92H513V6.35Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.157208333333328,6.263999999999999)scale(0.02866666666666665)">Multi-Treatment Models Breast Cancer GSE136823 3/Multi-Treatment Models Breast Cancer GSE136823 4</text></g><g class="point"><path d="M0,5.81V5.39H513V5.81Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.944249999999998,5.726)scale(0.027999999999999994)">Multi-Treatment Models Breast Cancer GSE136823 3/Multi-Treatment Models Breast Cancer GSE136823 6</text></g><g class="point"><path d="M0,5.28V4.85H513V5.28Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.708343750000015,5.194)scale(0.02866666666666671)">Stathmin and breast cancer resistance to antimicrotubule agents/Integrated Breast Cancer Pathway Homo sapiens WP1984</text></g><g class="point"><path d="M0,4.75V4.32H513V4.75Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(7.790166666666662,4.664)scale(0.02866666666666665)">Stathmin and breast cancer resistance to antimicrotubule agents/Cancer Stem cell:Breast</text></g><g class="point"><path d="M0,4.21V3.79H513V4.21Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(10.076937499999998,4.126)scale(0.027999999999999994)">Cancer Stem cell:Breast/estradiol human estrogen receptor (ER)-positive MCF7 breast cancer cells GDS3217 ligand:41</text></g><g class="point"><path d="M0,3.68V3.25H513V3.68Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.052395833333337,3.594)scale(0.028666666666666677)">Multi-Treatment Models Breast Cancer GSE136823 5/Differentially Breast Cancer Diabetes GSE150586 1</text></g><g class="point"><path d="M0,3.15V2.72H513V3.15Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(12.961812499999992,3.064)scale(0.02866666666666665)">Multi-Treatment Models Breast Cancer GSE136823 5/Interleukin-13 human Breast cancer - MCF10CA1a cell line (pLKO-shSCR) GSE57677 ligand:242</text></g><g class="point"><path d="M0,2.61V2.19H513V2.61Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.841874999999998,2.526)scale(0.027999999999999994)">Multi-Treatment Models Breast Cancer GSE136823 6/Differentially Breast Cancer Diabetes GSE150586 1</text></g><g class="point"><path d="M0,2.08V1.65H513V2.08Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.020395833333335,1.994)scale(0.028666666666666677)">Integrated breast cancer pathway/Integrated Breast Cancer Pathway Homo sapiens WP1984</text></g><g class="point"><path d="M0,1.55V1.12H513V1.55Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(6.7456249999999995,1.464)scale(0.028666666666666663)">Integrated breast cancer pathway/Integrated Breast Cancer Pathway WP1984</text></g><g class="point"><path d="M0,1.01V0.59H513V1.01Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(9.139812500000001,0.926)scale(0.028000000000000004)">Multi-Treatment Models Breast Cancer GSE136823 6/Breast Cancer C0006142 human GSE1379 sample 392</text></g><g class="point"><path d="M0,0.48V0.05H513V0.48Z" style="vector-effect: none; opacity: 1; stroke-width: 0.5px; fill: rgb(99, 110, 250); fill-opacity: 1; stroke: rgb(229, 236, 246); stroke-opacity: 1;"/><text class="bartext bartext-inside" text-anchor="middle" data-notex="1" x="0" y="0" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(255, 255, 255); fill-opacity: 1; white-space: pre;" transform="translate(8.628666666666666,0.394)scale(0.028666666666666667)">Integrated breast cancer pathway/Stathmin and breast cancer resistance to antimicrotubule agents</text></g></g></g></g></g><g class="overplot"/><path class="xlines-above crisp" d="M0,0" style="fill: none;"/><path class="ylines-above crisp" d="M0,0" style="fill: none;"/><g class="overlines-above"/><g class="xaxislayer-above"><g class="xtick"><text text-anchor="middle" x="0" y="433" transform="translate(80,0)" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(42, 63, 95); fill-opacity: 1; white-space: pre; opacity: 1;">0</text></g><g class="xtick"><text text-anchor="middle" x="0" y="433" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(42, 63, 95); fill-opacity: 1; white-space: pre; opacity: 1;" transform="translate(159.53,0)">50</text></g><g class="xtick"><text text-anchor="middle" x="0" y="433" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(42, 63, 95); fill-opacity: 1; white-space: pre; opacity: 1;" transform="translate(239.06,0)">100</text></g><g class="xtick"><text text-anchor="middle" x="0" y="433" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(42, 63, 95); fill-opacity: 1; white-space: pre; opacity: 1;" transform="translate(318.58000000000004,0)">150</text></g><g class="xtick"><text text-anchor="middle" x="0" y="433" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(42, 63, 95); fill-opacity: 1; white-space: pre; opacity: 1;" transform="translate(398.11,0)">200</text></g><g class="xtick"><text text-anchor="middle" x="0" y="433" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(42, 63, 95); fill-opacity: 1; white-space: pre; opacity: 1;" transform="translate(477.64,0)">250</text></g><g class="xtick"><text text-anchor="middle" x="0" y="433" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(42, 63, 95); fill-opacity: 1; white-space: pre; opacity: 1;" transform="translate(557.1700000000001,0)">300</text></g></g><g class="yaxislayer-above"><g class="ytick"><text text-anchor="end" x="79" y="4.199999999999999" transform="translate(0,419.73)" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(42, 63, 95); fill-opacity: 1; white-space: pre; opacity: 1;">0</text></g><g class="ytick"><text text-anchor="end" x="79" y="4.199999999999999" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(42, 63, 95); fill-opacity: 1; white-space: pre; opacity: 1;" transform="translate(0,366.4)">100</text></g><g class="ytick"><text text-anchor="end" x="79" y="4.199999999999999" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(42, 63, 95); fill-opacity: 1; white-space: pre; opacity: 1;" transform="translate(0,313.07)">200</text></g><g class="ytick"><text text-anchor="end" x="79" y="4.199999999999999" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(42, 63, 95); fill-opacity: 1; white-space: pre; opacity: 1;" transform="translate(0,259.73)">300</text></g><g class="ytick"><text text-anchor="end" x="79" y="4.199999999999999" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(42, 63, 95); fill-opacity: 1; white-space: pre; opacity: 1;" transform="translate(0,206.4)">400</text></g><g class="ytick"><text text-anchor="end" x="79" y="4.199999999999999" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 12px; fill: rgb(42, 63, 95); fill-opacity: 1; white-space: pre; opacity: 1;" transform="translate(0,153.07)">500</text></g></g><g class="overaxes-above"/></g></g><g class="polarlayer"/><g class="smithlayer"/><g class="ternarylayer"/><g class="geolayer"/><g class="funnelarealayer"/><g class="pielayer"/><g class="iciclelayer"/><g class="treemaplayer"/><g class="sunburstlayer"/><g class="glimages"/><defs id="topdefs-98d03e"><g class="clips"/></defs><g class="layer-above"><g class="imagelayer"/><g class="shapelayer"/></g><g class="infolayer"><g class="g-gtitle"/><g class="g-xtitle"><text class="xtitle" x="350" y="460.3" text-anchor="middle" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 14px; fill: rgb(42, 63, 95); opacity: 1; font-weight: normal; white-space: pre;">-log10(BH-corrected P-value)</text></g><g class="g-ytitle"><text class="ytitle" transform="rotate(-90,31.809375000000003,260)" x="31.809375000000003" y="260" text-anchor="middle" style="font-family: 'Open Sans', verdana, arial, sans-serif; font-size: 14px; fill: rgb(42, 63, 95); opacity: 1; font-weight: normal; white-space: pre;">Rank</text></g></g></svg>